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Abstract 
The focus of this project has been to explore practical applications of radiation dose 
optimisation in the clinical setting of the cardiac catheterisation laboratory. The relevance of 
interventional procedures and hence fluoroscopy, to modern cardiology practice, is 
illustrated, and the clinical significance of radiation dose management outlined. Current 
radiation dose management techniques, as well as the proposals for further dose optimisation, 
are detailed in this thesis.  
The first experiment in this project aims to establish an automated method of data collection 
for the monitoring of radiation dose optimisation techniques. A combination of open source 
programming languages and database management software has been used to create software 
that receives information directly from the fluoroscopic systems following patient procedures 
in the form of Radiation Dose Structured reports. All information about radiation exposure as 
well as study type, length and patient demographics are collected and stored. A further 
application of the software is to calculate the patient skin dose to monitor the likelihood of 
adverse tissue reactions following any high dose procedures. This information is then 
analysed and disseminated to operators to drive radiation dose optimisation. 
The second experiment in this project assessed the accuracy of the reported radiation dose 
metrics for different manufacturers collected in the above experiment. Fluoroscopic units 
used for cardiac catheterisation procedures are tested routinely for compliance. However, 
under Australian regulations, it is not required to validate certain metrics that impact on 
patient dose management. This study aimed to assess the accuracy of standard DICOM 
values used in patient dose calculations through direct measurement. The results indicate that 
the accuracy of the table height was dependent on the age of the unit, with older units varying 
by up to 4 cm. The reference air kerma and DAP were all within 10%. The FOV showed the 
greatest discrepancy from the directly measured value with up to 20% inaccuracy. The results 
of this experiment show that table height, and FOV should be directly measured and 
accounted for when calculating patient skin dose. This chapter also presents 
recommendations regarding the frequency and tolerance of testing. 
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The third experiment in this thesis addresses the feasibility of using a novel ‘ultralow’ 
fluoroscopic pulse rate during routine diagnostic coronary angiograms. Fluoroscopic pulse 
rate, one of the factors that influence patient dose in a coronary angiogram, is also under 
control of the operator and can thus be adjusted accordingly. Literature relating to reduction 
in fluoroscopic pulse rate as a means of radiation dose optimisation shows positive results. 
However, the resulting loss of diagnostic clarity has been a limiting factor. This study aimed 
to evaluate the effects of using an ultra low fluoroscopic pulse rate of 3 pulses per second on 
procedure duration, diagnostic clarity and radiation dose in an analysis of 50 coronary 
angiograms performed at a large metropolitan centre.  The results showed a statistically 
significant reduction in DAP (58%) with no reduction in diagnostic clarity or increase in 
procedure length. 
The fourth experiment uses the above results in conjunction with educational talks to 
practically apply radiation dose optimisation techniques at a large teaching hospital. Dose 
optimisation is particularly pertinent in teaching hospitals, where longer procedure times may 
be necessary to accommodate the teaching needs of junior staff, and thus impart a greater 
dose. The aim of this study is to analyse the effects of varying optimisation protocols in 
conventional coronary angiograms, from the perspective of a large tertiary centre 
implementing a rapid dose reduction program. Routine coronary angiograms were chosen to 
compare baseline levels of radiation, and the dose imparted before and after dose 
optimisation techniques was measured. Such techniques included lowering dose per pulse, 
pulse rate, frame rate and encouraging larger field of views and collimation. The results 
showed up to 54% dose reduction from a lowering of both frame rate and dose per pulse, 
without any adverse impact on clinical outcomes or teaching of junior staff.  
The fifth experiment focuses on the radiation exposure received by the operators in the 
cardiac catheterisation laboratory. Established research indicates potential long-term harm 
from low dose protracted radiation exposure to operators of cardiac angiography, with 
increasing exposure imparting greater risk. This experiment used a phantom model and 
thermoluminescent dosimeters to measure radiation dose to operators in a conventional 
coronary angiogram procedure, specifically looking at radiation dose to target regions of the 
operator to better examine clinical effects. Correspondingly, the results allow for a deduction 
of a comprehensive list of factors that allow the conversion from readily available patient 
dose metrics to operator dose. The study also found that basic monitoring using only a single 
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under apron dosimeter underestimates the radiation dose by up to 68%. Finally, the study 
provides recommendations to best mitigate the risk of radiation-induced disease through the 
use of radiation protection tools in high exposure regions of the body. 
The sixth and final experiment in this thesis outlines the production and evaluation of a real-
time radiation dose detector for the purpose of educational simulation and furthering 
understanding of radiation safety, and eventually clinical applications. Current conventional 
dose measurement methods, while clinically useful, are usually limited to retrospective 
analysis of dose only. In the cases where a real-time dose can be measured and displayed, the 
onus to continually assess the radiation dose visually adds cognitive load to the operator. This 
project examines the creation of a real-time dose detector that can provide visual, audible and 
tactile feedback to the interventional cardiologist. The aim of such a device is to provide 
ongoing feedback to the operator which can result in dose savings to the patient in real time 
via procedural modifications.  A prototype was created and tested, with calibration results 
showing that detector performance was comparable to available products and comfortable to 
wear for the operator. The vibration module providing tactile feedback can be programmed to 
either activate during increased dose rates (thus allowing procedural modifications) or 
following a set dose threshold, serving as a reminder that the procedure is resulting in a high 
patient and operator radiation exposure.  
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1 Introduction 
1.1 Interventional Cardiology 
Interventional cardiology, a sub specialisation of cardiology, involves the catheter-based 
management of coronary disease in both the acute and elective setting (Faxon and Williams, 
2012). The procedure involves inserting a sheath into a large peripheral artery which is then 
guided radiographically into the heart, allowing critical interventions. A wide variety of 
examinations and interventions are thus made possible. These include diagnostic coronary 
angiography (DCA), percutaneous coronary interventions (PCI), mitral valvuloplasty (MV), 
atrial septal defect closure (ASDC), diagnostic electrophysiology study (DES), 
radiofrequency catheter ablation (RFCA), pacemaker (PI) and defibrillator (DI) Implantation. 
Table 1.1 provides a summary of each procedure.  
Diagnostic coronary angiograms and percutaneous coronary interventions comprise a large 
volume of modern cardiology practice, both in the acute and elective settings (Australian 
Institute of Health and Welfare, 2016, Kočka, 2015). Andreas Gruentzig undertook the first 
instance of coronary balloon angiography in 1976, building on the work of others in the field 
of cardiac catheterisation (King, 1998).  This work, particularly the inadvertent arteriogram 
produced during left heart catheterisation by Sones, also paved the way for coronary artery 
bypass grafting. The success of PCI has meant that it has it is now the preferred over 
coronary artery bypass graft (CABG) surgery for treating coronary artery disease in Australia 
(Yan et al., 2011).  
Coronary artery disease (CAD) remains a major health burden in Australia, with it being the 
single leading cause of death nationwide in 2013 (Australian Institute of Health and Welfare, 
2016). While preventative strategies (e.g. smoking cessation) and an improvement in medical 
and surgical treatment have resulted in a decline in the mortality rate due to CAD, it remains 
a persistent concern in certain age groups, as well as in certain populations. In the period of 
2013-14, 149 000 hospitalisations occurred in which CAD was diagnosed, with 44% of these 
going on to have coronary angiography and a further 22% of these undergoing 
revascularisation. While there is a variation in the rate of angiography Australia wide, it is 
likely that the incidence of DCA and PCI is likely to remain constant or continue increasing 
(Chew et al., 2016).  
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Table 1.1 - Common interventional cardiology procedures. 
Procedure Description 
Diagnostic 
Coronary 
Angiogram  
Insertion of a catheter through a peripheral artery, and directed towards 
the major coronary arteries. Injecting a contrasting agent into the artery 
allows visualisation of the blood flow through fluoroscopic imaging. 
This diagnostic procedure precedes most interventional cardiology 
procedures, such as PCI, to see which area requires treatment. 
Percutaneous 
Coronary 
Intervention 
A sheath is inserted into a large peripheral artery (commonly the femoral 
or radial artery) and directed towards the problematic coronary artery, 
which is then mechanically unblocked by the removal of clots or 
increased in diameter via the use of balloons and stents (Mueller and 
Sanborn, 1995). 
Mitral 
Valvuloplasty  
The correction of a stenosis in the mitral valve, which lies between the 
left atrium and left ventricle in the heart. Access through a peripheral 
artery allows an inflatable balloon attached to a catheter to be directed 
through the inferior vena cava and into the right atrium. Puncturing the 
interatrial septum provides access to the mitral valve. Inflating the 
balloon dilates the valve, relieving the stenosis (Nishimura et al., 1990).  
Atrial Septal 
Defect Closure 
Passing an intracardiac device designed to close defects in the atrial 
septum (which divides the left and right atria) is achieved through 
catheterisation. The intracardiac device is implanted over the defect and 
held in place to fill the hole and prevent blood flow between the atria 
(Brecker and Gersh, 2006). 
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Radiofrequency 
Catheter Ablation 
Radiofrequency catheter ablation is the use of high frequency current to 
generate heat and destroy small regions of cardiac tissue responsible for 
abnormal electrical pathways. Following identification of abnormal 
electrical activity, under fluoroscopic guidance, the area requiring 
treatment is ablated using specialised catheters (Morady, 1999). 
Fluoroscopy plays an integral role in interventional cardiology, and hence 
DCA.  Fluoroscopy allows for real-time X-ray imaging of the body (as detailed below) and, 
in the case of DCA and PCI, allows for real-time monitoring of cardiac anatomy, shown in 
Figure 1.1. However, like all forms of ionising radiation, the use of fluoroscopy is not 
without adverse side effects which concern both the patient and the operator. The monitoring 
of fluoroscopically guided procedures in DCA thus presents an ongoing concern in radiation 
safety, the details of which follows below.  
 
Figure 1.1. Fluoroscopically obtained image of coronary arteries. 
1.2 Fluoroscopy 
Fluoroscopy is an imaging modality that allows for real-time X-ray imaging of the human 
body with high temporal resolution.  Placing the patient between a pulsed or continuous low 
dose X-ray beam and a detector allows for imaging. The images are then used to diagnose or 
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treat a patient by displaying the patient’s internal structure while the interventional 
cardiologist inspects the movement of a body part, his instrument, or an injected contrast 
agent. 
1.2.1 X-ray Production 
By applying a large potential difference (20-150 kilovolts) between an anode and a cathode 
in a vacuum, accelerated electrons can generate X-rays. The cathode (commonly a helical 
filament of tungsten wire) is the source of the electrons via the thermionic effect, whereby 
electrical resistance causes heating of the wire. Accelerating the electrons through the applied 
potential difference towards the anode (target) increases their kinetic energy. The target 
serves the purpose of converting the kinetic energy of the electrons to radiation and 
dissipating the thermal energy which is a by-product of the process. The majority of electrons 
that interact with the target deposit their energy in the form of heat following interactions 
with atomic electrons. However, a small percentage get into proximity with the positively 
charged nucleus of the target and decelerate and change direction. The deceleration of 
electrons occurs due to the Coulomb interactions with the nucleus. The energy lost in this 
process is conserved and emitted in the form of an X-ray photon (Figure 1.2). The created X-
ray photon is known as Bremsstrahlung radiation, a German word meaning braking radiation. 
 
Figure 1.2. A diagram of an X-ray tube and X-ray production (Anderson, 2000) 
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Selecting a high atomic number element for the anode increases the efficiency of the X-ray 
production process. Furthermore, the target material must be able to withstand high 
temperatures. The most common element that meets the above requirements and ordinarily 
used for the anode is Tungsten. Tungsten has a high melting point and can keep its shape and 
strength at high temperature, as well as having a relatively high atomic number (z = 74). The 
X-rays produced are of varying energies based on the type and distance of interaction from 
the nucleus (Bushberg and Boone, 2011). 
For the purpose of diagnostic information, low energy photons do not provide much value, 
however still contribute to the total patient absorbed dose. To decrease the number of low 
energy X-rays interacting with the patient, the produced X-rays pass through filtration 
material. The low energy X-rays are attenuated more readily by interacting with the filter 
material and being absorbed or scattered as lower energy photons. Filtration ensures the 
energies of the X-rays that interact with the patient are on average of higher photon energy, 
also known as beam hardening. Adjustable lead shutters, known as collimators, are then used 
to define the X-ray field to the patient's region of interest. The operator changing the field of 
view (FOV) settings controls the size of the X-ray field. 
1.2.2 Image Production 
As the X-ray beam passes through the patient’s body, it interacts differently with varying 
structures in its paths. Depending on the atomic makeup of the organs, the X-ray photons 
within the beam are absorbed differently. For example, as the X-rays pass through bone a 
greater number of photons are absorbed than X-rays passing through muscle tissue, due to the 
higher atomic density of bone. This variation in the intensity of the beam results in an 
attenuation map, which when passed through the detector and processed creates the internal 
image of the patient, thus comprising the fluoroscopic image. 
There are two main types of detectors used in fluoroscopy to create the patient images, Image 
intensifiers (II) and Flat Panel Detectors (FPD). IIs are the more conventional and older 
detector systems. It is a large vacuum tube that allows the X-rays to pass through with 
minimum unwanted interactions. The X-rays interact with and deposit their energy in a layer 
of phosphor; this converts some of their energy into light. The photocathode absorbs the 
light, which emits electrons proportional to the amount of light that was absorbed. A high 
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voltage through a series of dynodes accelerates the electrons to increase their kinetic energy 
and their amount. Once they are of sufficient energy, they interact with an output phosphor, 
which converts the electrons back into visible light. This light is of much higher intensity 
than the light emitted by the input phosphor. It passes through a lens, and a coupled television 
camera tube converts it into electrical signals that appear as the image on the monitor 
(Nickoloff, 2011). Figure 2.2 shows a diagram representing the II system process. 
 
Figure 1.3. Diagram representing the path of the incident X-ray and its transformation into a moving 
image on the CCD TV camera (Seibert, 2006). 
Two major FPD technologies have been implemented, based on the indirect conversion of X-
rays to light (using an X-ray scintillator) and then to proportional charge (using a 
photodiode), or direct conversion of X-rays into charge (using a semiconductor material) for 
signal acquisition and digitisation (Seibert, 2006).  In the indirect method, a caesium iodide 
crystal absorbs the X-ray photons and converts them to visible light. A low noise photodiode 
array absorbs the converted light photons and converts them into an electronic charge; each 
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photodiode is a representation of a pixel or picture element. The charge at each pixel is read 
out by low noise electronics and turned into digital data sent to an image processor (Figure 
1.4). 
The direct method involves the X-ray photon directly creating electron-hole pairs in a 
semiconducting material. The detector utilises a layer of amorphous selenium (a-Se) X-ray 
photon conductor superimposed upon a hydrogenated amorphous silicon (a-Si: H) active 
matrix. Absorption of the X-ray photons in the a-Se layer releases electric charge carriers 
directly. A bias voltage is applied across the a-Se layer to transfer the charge carriers to the 
appropriate signal electrode. Each electrode corresponds to a set of pixels on the unit, and this 
creates the image (Gomi et al., 2006). 
 
Figure 1.4. Schematic of an indirect flat panel detector (Béranger et al., 2011). 
A complex chain of electron optical components makes up the II TV system, which is subject 
to drifts and variations in adjustment over time that degrades clinical performances. Solid 
state digital detectors are more stable and require minimal QA monitoring. Solid state 
detectors also exhibit zero geometrical distortion and vignetting, immunity from blooming 
and negligible contrast loss due to internal scatter. They also exhibit a wider dynamic range 
and retain high spatial resolution. II systems are also more bulky and heavier than solid state 
FPDs and therefore provide worse accessibility and anatomical coverage for the patient. For 
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these reasons, the majority of new fluoroscopic equipment utilise some form of solid state 
FPD mechanism (Cowen et al., 2008). 
Modern imaging detectors make use of certain algorithms that control the system's response 
to changes in imaging conditions. One set of algorithms maintain an average absorbed energy 
at the imaging detector, which results in a constant signal and a bright image. This signal is 
preserved by automatically controlling the exposure parameters of the X-ray generator to 
achieve a similar exit dose if the beam passes through varying structures or different size 
patients.  This system is commonly known as the automatic brightness control (ABC) or 
automatic dose rate control mode of operation (Rauch et al., 2012) 
1.2.3 Pulsed Fluoroscopy 
Historically, continuous fluoroscopy has been the only method available for fluoroscopic 
systems. This method, involving the use of a continuous X-ray beam and a camera display of 
30 frames per second (FPS), was used on all analogue systems. The advent of modern 
technology has introduced the technique of pulsed fluoroscopy, where instead of a continuous 
X-ray beam a series of short X-ray pulses are used. Pulsed fluoroscopy increases the temporal 
resolution when used at 30 frames per second and can thus offer better image quality at a 
lower dose than continuous fluoroscopy.  
Another advantage of pulsed fluoroscopy is that even lower frame rates can be selected when 
the high temporal resolution is not required to lower overall radiation dose. For example, the 
initial guiding of a catheter in a DCA from the femoral access point to the aortic arch does 
not necessitate a high temporal resolution, and therefore pulsed fluoroscopy at lower pulse 
rates (5, 7.5, 15 FPS) can provide adequate image quality. The decreased pulse rate offers 
significant dose reduction without a lower image quality deleteriously impacting on the 
clinical outcome (Bushberg and Boone, 2011).  
1.3 Interaction Mechanisms of low energy X-rays 
As the typically low energy X-rays of fluoroscopy pass through a medium (air, patient tissue, 
patient bed, detector), they interact in two different methods; Photoelectric Effect and 
Compton Scattering. These effects lead to a partial or complete transfer of the photon energy 
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to the absorbing medium. The photoelectric effect occurs when the photon interacts with an 
atomic electron and transfers its energy completely to the electron. The incident photon 
disappears and an ejected electron with an energy value that is equal to the difference 
between the energy of the incident photon and the binding energy of the electron to its shell. 
The ejected electron leaves a hole in the electron shell, which is then occupied by more 
energetic electrons. As a consequence, as the electron emits its energy to occupy a lower 
electron energy state a characteristic X-ray is produced (Knoll, 2010). Figure 1.5 shows a 
simple diagram of the photoelectric effect. 
 
 
Figure 1.5 - A diagram of the Photoelectric Effect (Busse, 2004) 
Compton scattering occurs when the incident X-ray photon interacted with an electron in the 
absorbing medium and deflected through an angle θ from its original direction. The photon 
will transfer a portion of its energy to the electron, and the electron will recoil with an energy 
value equal to the difference between the incident photon energy and the energy imparted on 
the electron as a function of the scattering angle (Knoll, 2010). Figure 1.6 shows a simple 
diagram of the Compton scatter process. 
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Figure 1.6 - A diagram of Compton scattering (Nave, 2006) 
1.4 Radiation Biology 
1.4.1 Biological Effects of Radiation 
Ionising radiation deposits its energy randomly and rapidly within tissue via excitation, 
ionisation or thermal heating. Certain interactions will produce biological changes in either a 
direct or indirect manner. Direct interaction occurs when the ionising radiation interacts with 
critical targets such as DNA, RNA or proteins and directly ionises or excites them. Indirect 
interaction occurs when the ionising radiation interacts with a medium, such as cytoplasm, 
creating free radicals which interact with critical target macromolecules. 
Biological effect is dependent on the radiation dose, dose rate, environmental conditions, 
radiosensitivity and the spatial distribution of energy deposition. The Linear Energy Transfer 
(LET) describes the amount of energy deposited per unit length in units of eV/cm. The 
ionising radiation utilised in fluoroscopy is low LET radiation which is considered less 
damaging than high LET radiations such as alpha particles and heavy ions. 
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Figure 1.7. Direct and Indirect radiation interactions with DNA (Malloy et al., 2015) 
Following irradiation, cells can exhibit some responses which include: delayed cell division, 
apoptosis, reproductive failure, DNA mutations, phenotypic transformation, genomic 
instability, bystander effect (damage to neighbouring non-irradiated cells) and adaptive 
response (increased radioresistance). Some factors can affect the cellular radioactivity and 
what the cell response will be. The LET, which is low in the cardiac catheterisation 
laboratory, and dose rate play a significant role regarding the physical characteristics of the 
incident X-ray exposure. However, other factors that can affect the radiosensitivity of cells 
could be patient specific such as genetics, prior irradiation, disease states such as diabetes and 
connective tissue disease and treatments such as any cytotoxic drugs as well as the cycle 
status of the cell.  
The biological effects of radiation exposure manifest in two ways: stochastic and 
deterministic. If the patient exposed to a high amount of radiation in a short period that 
exceeds a certain threshold, they undergo tissue reactions due to cell death, also known as 
non-stochastic effects. Tissue reactions are observed soon after radiation exposure, and as 
they are non-stochastic, meaning the effect does not rely on probability, they will always 
manifest once exceeding the threshold. The severity of tissue reactions will increase as the 
absorbed dose increases above the threshold. The majority of tissue reactions in fluoroscopy 
affect the skin tissue, although damage to the eyes, hair loss and even death is possible at 
very high doses. Erythema (reddening of the skin), blistering, ulceration or necrosis of the 
skin are some of the effects that can occur following extended exposure during interventional 
 15 
procedures. Table 1.2 summarises the radiation skin injuries which range from mild erythema 
to severe blistering and even skin necrosis in some cases. Patients that have received more 
than 2 Gy to a single site of skin are at risk of skin changes, and the severity and long-term 
effects of the injuries increase with dose (Mettler et al., 2002, Mooney, 2000, Shope, 1996). 
Figure 1.8 is an example of adverse skin reactions following a fluoroscopically guided 
procedure. 
Stochastic effects are effects that are probabilistic in nature, meaning they may or may not 
occur in an exposed individual. These effects generally will manifest themselves years after 
the initial radiation exposure. The probability of the effect increases with more absorbed 
dose; however, one can not definitively associate the effect with the radiation exposure. Also, 
an increase in radiation dose does not have a consequence on the severity of the effect, and 
the most accepted theory suggests there is no minimum radiation dose threshold for which 
the effect could occur. Common examples of stochastic effects are cancer induction and 
genetic effects in the offspring of irradiated individuals (Stabin, 2007). 
 
Figure 1.8. A patient showing skin reactions following a complex cardiac interventional procedure 
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Table 1.2. Potential effects to the patient's skin from fluoroscopically guided procedures reproduced 
from Wagner et al. (Wagner, 2007). 
Effect  Single-dose threshold (Gy) Onset 
Early transient erythema 2 ~2-24 hr 
Main erythema  6 ~10 days 
Temporary epilation 3 ~3 weeks 
Permanent epilation 7 ~3 weeks 
Dry desquamation 14 ~4 weeks 
Moist desquamation 18 ~4 weeks 
Secondary ulceration 24 >6 weeks 
Late erythema 15 8-10 weeks 
Ischemic dermal necrosis 18 >10 weeks 
Dermal atrophy (1st phase) 10 >12 weeks 
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Dermal atrophy (2nd phase) 10 >1 year 
Induration (invasive fibrosis) 10  
Telangiectasia 10 >1 year 
Dermal necrosis (late phase) >12? >1 year 
Skin cancer  None known >5 year 
1.4.2 Radiation Epidemiology 
While there exist numerous examples in the literature of the risks of ionising radiation usage; 
the research is not without its limitations. The majority of the data about the effects of 
radiation was collected in what is known as the lifespan study, which followed 120 000 
human subjects following the explosion of the atomic bombs on Hiroshima and Nagasaki 
(Preston et al., 2003). The focus of this study was the calculation of the relative risk of solid 
cancers in atomic bomb survivors. A major limitation of this study was the non-homogenous 
populations comprising the control and the exposure group, with the control group subjected 
to a higher mortality rate from external factors. Furthermore, the energy of exposure in the 
exposure group is much greater than that which patients are subject to in a hospital setting. 
Nonetheless, several statements were concluded from the study, particularly relating to the 
age of exposure versus risk and the type of cancer. One important conclusion from the study 
was that there is no threshold of radiation dose at which the potential for eventual 
carcinogenesis is zero. The lack of threshold has been the key evidence to support the linear 
no-threshold model (LNT) which is currently the most accepted model by regulatory 
authorities. Since this model assumes that even a small amount of radiation can cause future 
malignancies radiation dose optimisation has followed a conservative model which states that 
radiation dose should be as low as reasonably achievable (ALARA).  
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More recent studies provide further evidence for the LNT model. Two studies addressing the 
risk of cancer in occupationally exposed workers in the nuclear industry (Cardis et al., 2007, 
Richardson et al., 2015) and another investigating the risk in 680 000 paediatric who 
underwent computed tomography (CT) scans (Mathews et al., 2013). Although all these 
studies have their limitations, it is still prudent to take the conservative approach and promote 
radiation dose optimisation in all medically exposed patients and occupationally exposed 
staff. 
1.5 Radiation Dose Measurement 
There are a number of radiation quantities that are used to express the effect of radiation in 
specific instances. The radiation quantities used to describe the radiation source, for example, 
are different to the quantities used to describe the radiation dose to the patient. Table 1.3 
outlines common radiation quantities used in interventional cardiology.  
Current patient dose monitoring techniques are mostly indirect measurements, meaning they 
are dose estimates at some defined location (usually the Interventional Reference Point as 
defined by the FDA or IEC) based on a direct measurement at another location. This method, 
although practical and economical, has many issues regarding accuracy when used for real-
time patient dose monitoring. Furthermore, if all geometrical and specific unit factors are not 
accounted for correctly by the staff post procedure, the estimated skin dose may have 
significant inaccuracies and will not be recorded properly in the patient files (Balter et al., 
2002a). 
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Table 1.3. Radiation quantities used in fluoroscopically guided procedure radiation dosimetry. Table reproduced from Mahesh (Mahesh, 2012). 
Quantity  Description Symbol SI Unit 
Incident air kerma Air kerma from the incident x-ray beam at beam axis at a certain source-to-
surface distance (SSD). 
Ka, i Gray (Gy) 
Entrance-surface air kerma Air kerma from the incident x-ray beam at beam axis at patient’s entrance 
point, including a contribution from back-scattered radiation. 
Ka,e Gy 
Point absorbed dose Energy absorbed per unit mass at a certain point in a medium including a 
contribution from back-scattered radiation. 
D Gy 
Entrance-surface absorbed dose Energy absorbed on the central x-ray beam axis at patient’s entrance point 
including a contribution from back-scattered radiation. 
Dskin,e Gy 
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Mean organ/tissue absorbed dose Integral or average absorbed energy over a whole tissue/organ mass. DT Gy 
Peak skin dose Energy absorbed per unit mass at the most irradiated local area of patient’s 
skin including a contribution from back-scattered radiation. 
Dskin, max Gy 
Air kerma at the reference point The air kerma (Ka) without any contribution of back-scattered radiation on a 
certain, regulated/standardised positions. In IEC standard, the position is 
defined at the central beam axis 15 cm away from the isocenter towards the x-
ray tube. 
Ka,r Gy 
Air kerma-area product The integral of air kerma without any contribution of back-scattered radiation 
over the area of the x-ray beam perpendicular to the beam axis. 
PKA Gy cm2 
FDA compliance air kerma rate Air kerma per unit of time measured under FDA compliance conditions. 
FDAK!  mGy / min 
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1.5.1 Indirect Measurement of Radiation 
Indirect measurement of radiation relies on the measurement of certain factors at one location 
and using those factors to estimate the radiation dose at another location. In the 
catheterisation laboratory, the measurement of Reference Air Kerma is an example of this. 
Direct measurement of Dose-Area product (DAP), discussed below, at the X-ray tube is 
corrected for distances, and displayed as the Air Kerma at a reference point. Additionally, 
sometimes DAP is not a direct measurement, instead a calculated value based on lookup 
tables from system parameters.   
1.5.1.1 Dose-Area Product 
DAP is the most common tool used to estimate the risk of tissue reactions. The DAP meter is 
typically an ionisation chamber installed past the collimators in the X-ray tube assembly. A 
transparent ionisation chamber intercepts the entire X-ray beam, and the dose measured is 
multiplied by the area irradiated. Due to the inverse square law and the divergence of the X-
ray beam; this value will stay constant through the entirety of the beam, i.e. as the area 
irradiated gets larger the intensity gets lower (Zoetelief, 2005). DAP is readily exchanged 
with Kerma-Area Product (KAP) since the photon energies used in diagnostic X-rays is 
approximately equal to absorbed dose (Kainz, 2006). Through the measurement of DAP, one 
can calculate the reference Air Kerma by correcting for distance to the reference point and 
the field size. 
1.5.1.2 System parameters 
Utilising system parameters as well as technical factors allows for the estimate of patient 
exposures without the use of any direct measurements. (Stern et al., 1995a, Suleiman et al., 
1991, Stern et al., 1995b). Geometrical relationship and system parameters, such as kVp, mA 
and time, calculations can be made to estimate the patient's maximum skin dose. The biggest 
problem with this method is that the system parameters do not provide enough information 
about the fluoroscopic dose rates (Balter et al., 2002b). 
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1.5.2 Direct Measurement of Radiation 
Although numerous methods exist to measure radiation directly, this chapter only introduces 
the ones directly pertinent to this thesis. 
1.5.2.1 Thermoluminescent Dosimeter 
A Thermoluminescent dosimeter (TLD) is a type of radiation dosimeter used in both patient 
and staff monitoring. As the ionising radiation strikes the material, the energy deposited frees 
an electron from the compound. The introduction of impurities in the crystal lattice allows the 
capture of free electrons in 'traps' between the valence and conduction band of the material. 
The vacated electron leaves behind a positively charged electron ‘hole’. Upon heating of the 
TLD, the electrons attain enough thermal energy to escape the trap and return to their original 
states in the valence band. Once the electron recombines with the positive electron-hole, they 
emit the excess energy as light. This excess energy is relative to the amount of energy 
absorbed through the interaction with the ionising radiation, i.e. the amount of light produced 
is proportional to the amount of radiation absorbed initially by the TLD (Horowitz, 1984). 
 
Figure 1.9. The interaction of ionising radiation with thermoluminescent detector material and the 
read-out process. 
 23 
In the clinical setting, a small TLD material such as lithium fluoride is mounted on 
aluminium plates and contained in plastic holders that are attached to the staff member’s 
clothing. The use of TLD is prevalent in staff dosimetry due to its sensitivity to detect the 
energies used, its mobility and its ability to store the accumulated dose information until it is 
read out and reset. The major disadvantage of TLDs in interventional cardiology dosimetry is 
that they provide no real-time information, which if available could allow dose modification 
manoeuvres during the procedure. The TLD must be processed post procedure to obtain dose 
information and can only be read once, meaning any errors in the process can lead to losing 
all the collected data. 
Since TLD chips do not interfere with the fluoroscopic image, are cheap and have suitable 
sensitivity they are common in both research and clinical settings for interventional 
cardiology. LiF, when used for patient dosimetry, is advantageous in that it has a low atomic 
number (effective z = 8.2) which makes it nearly tissue equivalent (effective z = 7.8). 
Furthermore, its response per unit dose is flat over a large range of X-ray energies. 
1.5.2.2 Ionisation Chambers 
Ionisation chambers used to measure radiation dose, consist of a gas medium within a 
housing containing an anode and a cathode. Inside the chamber, a potential difference is 
generated between the electrodes and the energy deposited by ionising radiation produces ion 
pairs. 
The charged particles, produced by the ionising radiation, transfers energy to the gas 
molecules to create the ionised molecule, and the minimum energy required to do so is called 
the ionisation energy. The production of the ionised molecule gives rise to a positive ion and 
an ion pair, i.e. a pair of electrons. A multitude of interactions occurs between the free 
electron pairs, the positive ions and the existing neutral gas molecules.  
Applying a potential difference allows for the charged particles to be attracted to the 
electrode containing the opposite charge, thereby generating a current. The potential 
difference is of a magnitude such that it is large enough to ensure collection of all ion pairs, 
yet small enough to prevent the creation of secondary ion pairs. This current can thus be 
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measured and related to the interactions occurring in the chamber - i.e. the radiation dose 
imparted. This process is simplified in Figure 1.10. 
 
Figure 1.10. Diagram of a simple gas-filled detector. 
The potential difference itself can be increased as needed, which causes a proportional 
increase of interactions (and thereby consequent ionisations) between particles in the 
chamber. This principle is named an ‘avalanche’ and is the basis for the operation of 
proportion counters and GM tubes. Figure 1.11 shows the operating voltage for different 
types of gas filled detectors. 
Types of ionisation chambers include pulse-type chambers and current-type chambers. Pulse-
type chambers generate pulses of voltage whereas current-type chambers utilise the anode to 
gather electrons via a modifiable direct current (Seco et al., 2014, Bushberg and Boone, 2011, 
Knoll, 2010).  
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Figure 1.11. Operating voltage of gas-filled chambers (Delaney and Finch, 1992). 
1.5.2.3 Geiger-Muller Tube 
The Geiger-Muller tube (G.M tube) more commonly known as a Geiger counter, provides a 
means of detecting/counting all forms of radiations. The device is simply composed of a 
cylindrical tube which encases a “detection” gas, commonly Argon, and at the centre of the 
tube lies a tungsten wire which serves as the anode for the application of a potential 
difference between the wire and cylinder. As such, when the apparatus is in the vicinity of a 
radiation source, some of the Argon gas undergoes ionisation which compounds the number 
of free electrons attracted towards the anode. It is to be noted here that a small amount of 
“quenching” gas required in the form of Bromine or alcohol vapour; this serves to absorb 
positively charged Argon ions (Knoll, 2010). 
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Figure 1.12. Discharge cycle initiated by initial ionisation of the gas and a high potential difference 
between the cathode and the anode (Knoll, 2010). 
The electrical discharge resulting from the ionisation of Argon atoms provides a measurable 
electrical pulse which is registered/converted into either clicks or a simple number. As the 
voltage required within the G.M tube is critical for detecting ionising radiation there exists an 
optimal range known as the plateau region. Within this region, the input voltage is 
represented by a consistent count. The regions above or below this range demonstrate either a 
continuous discharge or no accountable pulses respectively. The recommended plateau region 
lies between an operating voltage of 500V-2000V, which primarily varies on the size of the 
apparatus. Lastly, while the G.M tube provides accurate levels of detection/measurement of 
radiation, the depletion of quenching gases within the tube itself places a limited operational 
life, while a different combination of gas mixtures can increase the operational life (Abilama 
et al.).  
1.5.2.4 Semi-Conductor Detectors 
Semiconductor detectors rely on semiconducting materials (e.g. silicon) doped with 
impurities that can provide free electrons in the conducting band (p-type) or holes in the 
valence band (n-type). By applying a potential difference between two terminals either side 
of the semiconducting material, when ionising radiation interacts with the detector element, a 
flow of current relative to the radiation exposure is generated and results in a pulse. 
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An advantage of semiconductor detectors is that they exhibit a linear response to X-ray 
energies in the diagnostic range. Furthermore,  they are small, have a fast response rate, 
absorb virtually no energy at the detector entrance and can resolve a broad spectrum of 
energies (Seco et al., 2014). 
1.6 Thesis Objective 
The aims of this thesis are to explore different methods to increase awareness and 
consequently optimise radiation dose in interventional cardiology.  
The development of software which automates radiation dose data management as well as 
provides radiation dose calculations to help in predicting adverse effects is paramount in 
increasing awareness. This software will indirectly optimise radiation dose in the 
catheterisation laboratory through three methods:  
1. Establishing a vendor-neutral database where the radiation exposure subjected on a 
patient during fluoroscopically guided procedures is recorded and can be audited and 
routinely compared to hospital medians, providing impetus to ensure ongoing 
radiation dose optimisation. 
2.  Establishing a vendor-neutral database where radiation dose optimisation techniques 
can be monitored to assess if the method yields statistically significant reductions in 
patient radiation exposure. 
3. Providing feedback to operators regarding the risk of adverse tissue reactions to the 
patient following extended procedures which enables the timely review of procedural 
methods and discussion surrounding how to lower the radiation to the patient in future 
cases. 
It is imperative that the radiation dose metrics provided by the vendors be accurate for the 
data collected to be usable. Another aim of this thesis is to validate the accuracy of 
measurements and factors that are reported by the fluoroscopy unit and used in patient dose 
calculations. The results of this can be used to build quality assurance programs that include 
regular testing of factors and measurements that may deviate from factory specifications over 
time. 
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Following the investigation of the accuracy of the methods established in this thesis to 
perform data collection, investigation of radiation dose optimisation techniques will occur. 
Due to the motion of the heart, high frame rates are required to reduce motion blur. The 
temporal resolution has historically driven the use of 15-30 frames per second for cardiac 
imaging. This thesis aims to explore if it is possible to reduce the pulse rate down to 3 pulses 
per second during the fluoroscopic guidance of catheters and stents without impacting the 
clinical outcomes of the procedure. In the cardiac clinical setting, the literature is typically 
limited to pulse rates as low as 7.5 pps. 
Education is provided to cardiologists at large metropolitan teaching hospital with the aim of 
systemically lowering radiation dose. This chapter will build on the results from the ultra-low 
pulse rate experiment and collected data regarding the medians for a routine coronary 
angiogram. The educational talks revisit known methods of dose optimisation techniques as 
well as introduce the results of using ultra-low pulse rates. Data is collected and assessed to 
see if significant optimisation is possible at teaching hospitals without impacting clinical 
outcomes or training requirements of junior staff. 
There has been recent literature published showing potential occupational risks for the 
interventional cardiologist in historically unshielded areas of the body. This thesis aims to 
monitor the radiation dose received by different regions on the operator’s body in a simulated 
coronary angiogram. This data is then used to advice on the needs for extra radiation 
protection to mitigate these risks as well as lower the overall staff radiation effective dose. 
Another recommended method of dose optimisation for the operator suggested in this thesis 
is real-time operator feedback.   
This thesis develops a cheap and mobile real-time detection system for use in the teaching 
environment. This product will provide instantaneous feedback in a simulated environment to 
highlight the relationship between the operator’s behaviour and radiation dose. As well as 
established methods, such as visual and audible signals, this thesis introduces tactile feedback 
to the system. Tactile feedback would allow the operator to focus on the clinical procedures 
without the need to constantly observe their radiation dose. The system would provide weak 
vibrations when dose rates are high which would encourage the operator to modify their dose 
behaviour and see the direct results of this change in real-time.  
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As each chapter in this thesis is a stand-alone experiment, it will contain an introduction, 
methods, results, discussion and conclusion related specifically to the experiment.  
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2 Literature Review 
The prevalence of interventional cardiology procedures warrants close monitoring of the 
radiation dose imparted. Considerable evidence exists in the literature to suggest that there 
are adverse effects associated with the use of ionising radiation for both the patient and the 
staff.  The linear dose-dependent manner of the effects is the basis of keeping the dose As 
Low as Reasonably Achievable (ALARA).  
Radiation dose management relies on the accurate reporting of the radiation dose delivered 
and the ability to audit following optimisation procedures, as well as an understanding of the 
clinical manifestations (short and long term) of adverse events. In the case of patient dose, an 
understanding of the usual (or expected) dose imparted for each procedure is also important. 
For operator dose, knowledge of available radiation shielding methods and their utility, as 
well as the appropriate use of dose feedback methods, is clinically significant. 
This chapter will present a review of the literature relating to patient dose and operator dose, 
its measurement and optimisation. 
2.1 Patient Dose 
2.1.1 Patient Mortality from Radiation Exposure 
Radiation exposure from fluoroscopically guided procedures has the potential to induce 
harmful side effects to the patient. The main stochastic effects discussed in radiation-induced 
injuries are cancer and genetic defects (Rao, 1998). Organs most at risk for induced cancer 
are the lungs, childhood thyroid, colon, bone marrow, bladder and the female breast. The 
National Research Council summarises the risk of stochastic effects per 0.1Gy of dose 
(National Research Council . Committee to Assess Health Risks from Exposure to Low 
Levels of Ionizing Radiation, 2005). Many studies have investigated the mortality rate from 
cancers potentially caused by exposure from fluoroscopic procedures (Boice Jr et al., 1991, 
Davis et al., 1989, Howe, 1995, Howe and McLaughlin, 1996, Doody et al., 2000). The risk 
of genetic defects in common procedures is investigated in varying studies (Perisinakis et al., 
2001, Calkins et al., 1991).  
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In the older adult population, the advantages of the cardiac procedure far outweigh the 
clinical likelihood of radiation-induced fatal cancer in their lifetime. However, in the 
paediatric setting, the lifetime cancer risk increases dramatically, and further justification and 
optimisation may be necessary. Studies have reported the cellular damage and radiation-
induced cancers following pediatric fluoroscopic procedures (Bacher et al., 2005, Ait-Ali et 
al., 2010, Andreassi, 2009, Beels et al., 2009, Andreassi et al., 2006). 
2.1.2 Tissue Reactions 
A review on the radiation effects on a patient’s skin by Balter et al. suggests that although a 
patient may not exceed a dangerous amount of skin dose in one procedure, the skin dose over 
multiple procedures also poses a significant risk (Balter et al., 2010). Therefore, the history of 
previous irradiations is important when estimating the expected tissue reaction from 
additional procedures (Mooney, 2000). Thus, it is paramount that there are an accurate means 
of estimating the patient skin dose in every procedure. An addition of errors in several 
procedures will alter the accuracy when calculating the accumulated dose from multiple 
procedures. 
A study done by Tsapaki et al. showed that out of 505 patients monitored for general 
interventional radiology procedures, 100 exceeded the 2Gy threshold for deterministic 
radiation effects (Tsapaki et al., 2009). This study highlights the need for better management 
of patient exposure to minimise deterministic radiation effect risk.  Another study conducted 
in Northern Ireland found that the fluoroscopic times required in the cardiology laboratories 
examined must exceed 10 hours for an average patient to exceed the threshold dose of 10 Gy 
for serious skin injury. Therefore, the risk of serious tissue reactions from interventional 
cardiology procedures is minimal. However, if a larger patient is examined the time 
fluoroscopic time required to reach 10 Gy could decrease to 70 minutes due to the increased 
dose rate (Mooney, 2000). 
Apart from skin injuries, another deterministic effect of ionising radiation associated with 
interventional fluoroscopy is cataracts to the patient. The threshold dose for a radiation-
induced cataract is 0.7 Gy (Worgul et al., 2007). However, since the patient's eyes are never 
in the primary beam during exposure, this should not be an issue (Hirshfeld et al., 2005).  
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Radiation-induced hair loss is another possible side effect following interventional 
fluoroscopic procedures (D'incan et al., 2002, Tosti et al., 1999, Imanishi et al., 2005).  
However, these incidents are rare and temporary, with the effects typically regressing within 
four months (D'incan et al., 2002). 
2.1.3 Radiation Measurement 
During fluoroscopically guided procedures indirect measurement techniques are employed to 
monitor the X-ray radiation output. These are sometimes incorrectly used as a surrogate for 
patient skin dose. Studies have explored the correlation of patient dose to the indirect 
measurement techniques. 
Chida et al. compared the dose measured at the reference point in 13 fluoroscopic X-ray 
units. The displayed dose on 7 of the 13 tested units was in agreement to the measured dose 
at the reference point (within ±15%). On the other six units, the dose was approximately half 
the measured values. The non-agreement may be due to the fluoroscopic units being 
manufactured in different countries and having a different reference point. This study 
highlights the importance of routinely monitoring the accuracy of the displayed dose at the 
reference point. Understanding the different regulations regarding interventional reference 
points may lead to better indirect dose estimations (Chida et al., 2011). 
Chu et al. used Gafchromic Film® to correlate peak skin entrance dose to the more readily 
available parameters: dose area product and fluoroscopy time. The coefficient of 
determination (R2) between the directly measured dose and the dose area product, 
fluoroscopic time and the calculated effective dose 0.48, 0.46, and 0.09 showing a weak 
correlation. The results of this study indicate that current estimation methods do not provide 
values which correspond closely to the directly measured dose at the patient's skin (Chu et 
al., 2006). 
Chida et al. investigated the correlation between maximum skin dose and fluoroscopic time. 
The study found that there is a good correlation (r = 0.801) between fluoroscopic times and 
maximum radiation skin dose in radiofrequency catheter ablations. However, there was a 
modest correlation (r = 0.628) in percutaneous coronary interventions. The correlation for 
dose area product and maximum skin dose was stronger for both procedures with r = 0.942 
 33 
and r = 0.742 for both radiofrequency catheter ablations and percutaneous coronary 
interventions respectively. This result suggests that using DAP as an indicator of maximum 
skin dose will yield more accurate results than fluoroscopic time (Chida et al., 2006). 
Kwon et al. used linear regression formulae to obtain accurate peak skin dose estimations 
from displayed reference air kerma and dose-area product. The study found that by using 
both the reference air kerma and kerma-area product in conjunction, an accurate estimation of 
the peak skin dose is obtainable using linear regression. If both methods are not available, 
regression analysis from the reference air kerma alone is more accurate than the kerma-area 
product (Kwon et al., 2011).  
Bogaert et al. suggested Dose-area product action levels by correlating maximum skin dose 
using TLD chips and displayed dose area product values. It is recommended that after a 
patient surpasses these action levels, they receive clinical follow-up for deterministic 
radiation effects (Bogaert et al., 2014). 
2.1.4 Radiation Management 
Real-time patient dose monitoring has enabled operators to optimise dose during procedures, 
as well as provide accurate documentation in patient records for surveillance of tissue 
reactions. Some tools are available to estimate patient skin dose in real time, including the 
Toshiba Dose Tracking System (DTS), Siemens CareGraph system, GE DoseMap and 
PEMNET. Of these, the PEMNET was the first to be developed. The PEMNET was an 
accurate and convenient method of monitoring patient dose and was a useful teaching tool in 
predicting tissue reactions, as well as practically evaluating the trade-off between image 
quality and patient dose (Gkanatsios et al., 1997). However, the downsides include not taking 
into account overlapping fields from several sources and the complexity involved in its 
installation (Mahesh, 2001).  
The Siemens CareGraph used mathematical models to monitor real-time skin dose, with 
reports of estimation of peak skin dose within 15% accuracy in the anterior-posterior plane 
(Ozeroglu, 2005). However, an underestimation of 67% in the lateral planes proved a 
downfall and a lack of demand eventually lead to discontinuation of the system. A similar 
system developed and tested by Toshiba showed dose distribution correlated well with 
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directly measured values. The software was found to estimate dose rate at patient skin within 
10% (Bednarek et al., 2011, Rana et al., 2011). The GE DoseMap system was introduced in 
2013 to monitor real-time dose in fluoroscopic units, however, at the time of writing, no 
studies validating this system currently exist. 
Current real-time dose monitoring tools are limited in that they are expensive and often 
manufacturer-bound, resulting in the technology not being widely used. Furthermore, very 
little literature exists that explores the effects of real-time dose monitoring devices on 
operators, i.e. whether they alter the behaviour of the operators, or are they largely ignored by 
the staff, having no real benefits beyond dose record keeping. Nevertheless, there exists a 
need for a simple, affordable real-time radiation dose management tool that works across 
different manufacturers. 
2.1.5 Radiation Exposure to the Patient 
Table 2.1 presents the typical patient radiation dose for cardiology procedures. The 
measurement of dose and reporting of it is paramount to radiation dose optimisation. 
Radiation dose values found in the literature are used as benchmarks when undergoing 
optimisation programs. This chapter presents a review of studies that have quantified 
radiation dose and explored radiation dose optimisation techniques. 
Ubeda et al. found that radiation dose levels in varying scenarios tested using a polymethyl 
methacrylate (PMMA) phantom were significantly higher than accepted values. They also 
found that significant variations in dose existed for the same procedures. These varying dose 
levels found for similar procedures suggests that there is room for optimising procedure 
protocols to lower the dose rate to patients (Ubeda et al., 2013).  
Dose optimisation techniques explored in the literature target pulse rate and frame rate, as 
well as determining optimal positioning. Kuon et al. (2014) were able to achieve reductions 
in mean DAP from 53.9 to 12.9 Gy cm2 for routine coronary angiography/angioplasty during 
a focused, year length study. The dose saving was achieved through a reduction in 
cinegraphic frames/runs, fluoroscopy time, finding the optimal positioning of blinds and 
filters and favouring low radiation views for visualisation of the left anterior descending 
(LAD) and diagonal arteries. Patient size (BMI), coronary artery disease pattern, tube 
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angulation, the urgency of the clinical situation and the target artery involved are relevant 
factors that influence DAP. The choice of cranial posteroanterior views over the traditional 
left anterior oblique views for viewing the left anterior descending artery and the diagonal 
artery achieved a mean DAP of 10.4 Gy.cm2 and 8.6 Gy.cm2. These are significantly lower 
from those of other arteries (right coronary artery 13.3 Gy.cm2, left circumflex artery 13.7 
Gy.cm2 and obtuse marginal branch 16.9 Gy.cm2) (Kuon et al., 2014).  
Similarly, a four-step program implemented by Seiffert et al. (2015) showed a 54% reduction 
DAP following a frame rate reduction, the use of fluoroscopy storage and strict use of beam 
collimation. Their program comprised a package of protocols implemented over the course of 
a year that aimed to reduce frame rates, use fluoroscopy storage, beam collimation and re-
education on radiation safety. Their single centre study evaluated the effects of this program 
over the course of six months as compared to a period of six months before the application of 
the program and included 3107 procedures of patients undergoing DCA or PCI (Seiffert et 
al., 2015). McFadden et al. (2013) showed a dose reduction of up to 49% in a paediatric 
phantom study by lowering the CINE frame rate from 30fps to 15fps with small reductions in 
image resolution (McFadden et al., 2013).  
A study was done to evaluate the effective dose for standard coronary angiography 
procedures in Norwegian heart-transplant patients undergoing annual surveillance coronary 
angiography using the dose-area product. By using historical patient data, the average 
accumulated effective dose for patients undergoing coronary angiography was 34 mSv. Heart 
transplant patient usually requires low dose during check-up procedures. The check-ups 
provide a low clinical risk for the average middle-aged patient with a limited life expectancy. 
However, in young patients with longer life expectancy, radiation dose reduction methods 
should be applied to lower the risk of stochastic radiation injury (Seierstad et al., 2012). 
Another study was done to assess the patient effective radiation dose in radiofrequency 
catheter ablation procedures. Dose measurements of 15 different organs are obtained using 
TLD chips in a phantom study. The results indicated that on average the patient effective 
dose was 8.3 mSv per hour of fluoroscopy in RF catheter ablation procedures. This effective 
dose results in a risk of 650 cases of fatal cancer per million patients. These results show 
radiation risk from RF catheter ablation procedures exceeds that of most common 
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radiological procedures (Perisinakis et al., 2001). These risks further highlight the importance 
of optimisation of patient dose. 
Patient mean skin dose is also highly dependent on patient size. An increase of 3 cm 
thickness of a patient results in twice the entrance dose if all other operating factors remain 
constant. This increase is due to the patient entrance dose being adjusted according to the 
patient thickness to achieve the required exit dose to form the image (Cusma et al., 1999). 
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Table 2.1. The radiation dose for the patient from common cardiac interventional procedures in mSv from recent literature.  
DCA PCI BV ASDC DES RFCA PI DI Year Reference 
- 5.0-16.7 - - - - - - 2000 Katritsis, D., et al. (Katritsis et al., 2000) 
- - - - - 17.0 - - 2002 McFadden, S., et al. (McFadden et al., 2002) 
20.9 23.2 - - - - - - 2003 Delichas, M., et al. (Delichas et al., 2003a) 
2.7-8.8 5.7-15.3 - - - - - - 2004 Stisova, V. (Stisova, 2004) 
- 14.0-15.0 - - - - - - 2004 
Efstathopoulos, E.P., et al. (Efstathopoulos et al., 
2004) 
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- - - 16.2 - - - - 2005 Papadopoulou, D.I., et al. (Papadopoulou et al., 2005) 
- - - - - - 5.3 5.6 2005 Perisinakis, K., et al. (Perisinakis et al., 2005) 
5.6 - - - - - - - 2006 Coles, D.R., et al. (Coles et al., 2006) 
- - - - 3.2 15.2 - - 2006 
Efstathopoulos, E.P., et al. (Efstathopoulos et al., 
2006) 
4.4 - - - - - - - 2007 Vijayalakshmi, K., et al. (Vijayalakshmi et al., 2007) 
7.0 - - - - 15.0 - - 2008 Mettler, F.A., et al. (Mettler et al., 2008) 
8.0 15.0 - - 6.0 - - - 2008 Padovani, R., et al. (Padovani et al., 2008) 
 39 
7.0 15.0 - - 5.7 - 1.5 - 2010 Chen, J., et al. (Chen et al., 2010) 
5.1-6.6 11.2-17.0 - - - - - - 2014 
Morrish, O. and K. Goldston (Morrish and Goldstone, 
2008) 
7.0 15.0 39.0 - - 15.0 - - 2014 Steiner, R. (Steiner, 2014) 
* DCA – Diagnostic Cardiac Angiogram, PCI – Percutaneous Coronary Intervention, BMV – Balloon Valvuloplasty, ASDC – Arterial Septal 
Defect Device Closure, DES – Diagnostic Electrophysiology Study, RFCA – Radiofrequency Catheter Ablation, PI – Pacemaker Implantation, 
DI – Cardiac Defibrillator Implantation. 
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2.2 Operator Dose 
2.2.1 Introduction  
The two largest sources of radiation exposure to staff in the cardiac catheterisation laboratory 
are scattered X-ray photons from the patient’s body and X-ray tube leakage. Ionising 
radiation poses a health risk to staff members in the catheterisation laboratory in the form of 
stochastic or tissue reactions. Stochastic effects describe the probability of cancer induction 
or DNA damage due to ionising radiation. This effect is believed to have no threshold 
radiation dose, and the chance of the effect increases linearly with increasing dose. On the 
other hand, tissue reactions, such as skin injury due to radiation exposure, have a threshold 
dose below which the probability of causing harm is zero. In the context of staff in the 
cardiac catheterisation laboratory, tissue reactions are rare. The rarity is due to the 
comparatively large threshold dose required for the effect to manifest. 
 
Table 1.3 summarises the quantities and measures of radiation dosimetry in this setting. Table 
2.2 summarises the typical dose received by operators for different cardiac procedures. The 
lens of the eye is a region of particular interest with a number of studies showing an increased 
incidence of cataracts amongst staff (Vano et al., 2010, Vano et al., 2013, Ciraj-Bjelac et al., 
2010, Jacob et al., 2013, Rehani et al., 2011). The occupational effective dose limit for 
radiation workers is 20 mSv per year averaged over five years, and the dose limit for the eye 
has recently been reduced from 150 mSv to 20 mSv a year to further protect against the rising 
number of radiation-induced cataracts (International Commission on Radiological Protection, 
2011). The occupational effective dose limit is believed to reduce any radiation-induced 
injury to staff members since doses below 100 mSv accumulated over a year do not appear to 
have any statistically significant association with carcinogenesis (International Commission 
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on Radiological Protection, 2007). There is evidence to suggest that leukaemia, carotid artery 
atherosclerosis and early vascular ageing may be a side effect of low protracted radiation 
exposure (Leuraud et al., 2015, Andreassi et al., 2015). Therefore, efforts need to be made to 
keep the dose as low as reasonably achievable (ALARA principle), regardless of 
occupational dose limits.  
 
Radiation-attenuating material, such as lead, has long been used as a component of protective 
equipment to decrease the amount of radiation received by staff. These include aprons, 
glasses and gloves as well as movable shields and with appropriate use will lower radiation 
exposure. Implementing radiation dose feedback may also have a role in reducing exposure. 
This paper reviews the available tools to lower dose to the operator during diagnostic and 
interventional cardiac procedures. 
2.2.2  Radiation Shielding 
2.2.2.1 Caps 
Reports regarding operator brain tumours associated with fluoroscopically guided procedures 
have raised concerns regarding appropriate shielding to the head (Finkelstein, 1998, Roguin 
et al., 2012, Hardell et al., 2001). Although the risk of malignancy is thought to be low, lead 
caps introduced in the past have been shown to be effective in lowering the exposure to the 
head. Furthermore, the use of lead caps has been demonstrated to reduce the dose to the head 
by up to 30 times more than ceiling mounted lead shields (Kuon et al., 2003, Karadag et al., 
2013). However, the average weight of these caps is 1.14 kg, which may be uncomfortable to 
wear and could present an occupational health and safety hazard. Back problems are 
prevalent amongst interventional cardiologists due to the necessity of wearing a lead apron 
(up to 7 kg) and adding extra weight to what is already standard is not an optimal solution 
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(Goldstein et al., 2004, Ross et al., 1997). A recent study tested the radioprotection efficacy 
of new lightweight lead equivalent caps containing a barium sulphate-bismuth oxide 
composite (Uthoff et al., 2015). These caps when worn in addition to the standard use of 
other radioprotective tools provided up to 90% dose reduction to the head, weigh an average 
of 125g and are comfortable to wear. A study using an even lighter cap containing the same 
materials and weighing approximately 50g was found to reduce the radiation dose to the head 
by 80% (Alazzoni et al., 2015). Although they are reusable, the lifespan of a cap is unknown 
and will depend on its care. 
Radioprotective caps do provide substantial dose reduction, however, whether they prevent 
radiation-induced illness is unknown. The cost of a lightweight radioprotective cap at the 
time of writing is about $10 AUD, but there are insufficient data to comment on cost-
effectiveness. These caps may be of use in cardiac procedures likely to give rise to increased 
operator radiation dose. There is evidence to suggest that dose to the head is greater in 
operators under 180cm in height, with a decrease in dose to the head of 1% per cm of 
operator height(Kuon et al., 2003). Hence, the caps may be of greater benefit to operators of 
shorter height. 
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Figure 2.1. An image of the RADPAD NO BRAINER, a lightweight, lead-free, disposable radiation 
protection cap. Image supplied by Teleflex Medical Australia. 
2.2.2.2 Gloves 
The hand receives a significant amount of radiation (45-1500 µSv per procedure) during 
procedures since it is unshielded and close to the radiation source (Vano et al., 1998). 
However, this level of exposure is unlikely to cause any adverse health impact. If dexterity is 
required; large leaded gloves are available but may be cumbersome. The use of radiation 
attenuating latex gloves (lead or lead-free) introduced in some centres helps address these 
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issues. These gloves according to manufacturer claims can shield the hand by up to 58% 
(Ansell Limited, 2009). However, placing a hand with an attenuating glove in a direct 
radiation beam will increase the dose to both patient and operator. The increase is due to the 
automatic brightness control system attempting to maintain a high signal at the detector by 
boosting the radiation output (Figure 2.2). The best method to protect the hands would be to 
keep them away from the primary beam. In cases where the hands must be close to the 
patient such as during a fluoroscopically guided vascular puncture, protective gloves may be 
an option. However, procedural modifications such as using a long needle or syringe to 
extend the working length of a needle may be preferable. If gloves are necessary, the use of 
single-use non-lead radioprotective gloves would be more environmentally friendly. 
 
Figure 2.2. Images were taken using a 15-cm patient equivalent Perspex phantom without (top left) 
and with leaded gloves (top right) and the increase in kV, mA and dose are highlighted in the 
structured radiation dose report (bottom). 
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2.2.2.3 Eyewear 
Radiation-induced cataracts in operators and nursing staff are a well-documented risk. Up to 
52% of subjects who have worked for extended periods in the catheterisation laboratory 
presented with radiation associated lens changes. (Ciraj-Bjelac et al., 2010, Jacob et al., 2013, 
Vano et al., 2010, Rehani et al., 2011). Some studies show that using leaded glasses lowered 
the dose to the lens by up to 98% (Burns et al., 2013, RE, 1987, Thornton et al., 2010). A 
study comparing lead glasses to plastic and non-lead glass lenses showed that the dose 
reduction to the lens in lead glasses was 87% as compared to 36% with non-lead glass and 
0% while wearing plastic lenses (Marshall et al., 1992). These results confirm that operators 
who use their optical glasses, commonly made from plastic lenses, will not protect the eyes 
from the detrimental effects of radiation. In another study, a lead acrylic face mask that was 
developed to safeguard the sides of the eyes was shown to reduce the radiation exposure to 
eyes by up to 97%  (Marshall et al., 1992). This reduction in dose highlights the importance 
of having glasses that also provide lateral shielding. There is enough evidence for radiation 
associated lens changes to give consideration to the use of lead glasses in addition to a ceiling 
mounted shield. 
 
Figure 2.3. Leaded glasses weighing 71g that can be worn to provide significant protection from 
scattered radiation to the lens of the eye. 
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2.2.2.4  Wearable Aprons 
Lead aprons are very efficient in lowering the radiation exposure to the operator and as such 
are part of standard safety practice in all clinics. The apron fit is important especially under 
the arms since significant gaps could introduce an increased exposure to breast tissue, which 
is relevant in female staff (Balter et al., 2012). However, as mentioned earlier, the additional 
weight of the apron, which is around 7 kg, places staff at a risk of developing back problems 
(Papadopoulos et al., 2009). A custom fitted two-piece lead garment may shift some of the 
weight from the shoulders to the hips. Utilising other protection methods may allow for 
weight reduction by selecting a less attenuating apron. Currently, the lead composite or lead-
free materials utilised in production aprons has resulted in a weight reduction of 20-40%. 
These aprons typically weigh around 4 kg (Papadopoulos et al., 2009), while maintaining a 
similar lead equivalence. Even lighter protective materials are under investigation. For 
example, a  phantom study showed that a lead-free bismuth-based material provided excellent 
shielding. However, it was slightly less effective than a standard lead apron, particularly on 
the operator side nearer the patient (Sawdy, 2009).  
The apron lead equivalence requires validation when received by the cardiac catheterisation 
laboratory. A study showed that 73% of tested aprons resulted in a lead equivalence lower 
than the tolerance levels required even though there were no significant faults found in the 
apron when scanned (Finnerty and Brennan, 2005). Lead equivalence of the apron may differ 
from the manufacturer stated value in the laboratory. This difference is due to the laboratory 
conditions and the reference test conditions being different. Aprons should be quality 
checked annually for any defects to ensure that no cracks in the radioprotective layer form 
that will allow radiation through to the wearer. The check is done by placing the apron flat on 
the table of a fluoroscopic system and examining it for breaks while panning the table 
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position to cover the entire item. Aprons must be handled carefully and stored safely on 
purpose designed lead apron racks to ensure that the integrity of the shielding material 
remains intact. The aprons must not be folded or creased during storage. 
2.2.2.5 Thyroid Collar 
The thyroid is a radiosensitive organ and has been linked to an increased risk of 
carcinogenesis from external ionising radiation (Ron et al., 1995). However, these results are 
limited by the age range of the subjects in these studies, with limited risk seen after exposure 
beyond the age of 20 years. Nevertheless, the thyroid of the operator will receive significant 
scattered radiation from the patient if unprotected. Therefore, thyroid shields should always 
be worn, with attention to minimising any gaps between the thyroid shield and the lead apron. 
Thyroid shields should also be quality checked annually using the same method described 
above for the wearable apron. 
 
Figure 2.4. Thyroid collar usually is worn under the lead apron 
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2.2.2.6 Ceiling mounted shields 
Ceiling mounted lead glass shields are common and if positioned correctly can lower the 
radiation dose to the operator’s head and neck (Fetterly et al., 2011, Thornton et al., 2010, 
Maeder et al., 2006). However, no significant dose reduction to the hands can be expected 
(Maeder et al., 2006). A study showed that although ceiling mounted shields do decrease the 
overall dose, they reduced exposure by a much smaller factor than expected for the 
attenuation figures stated by the manufacturer (Donadille et al., 2011). However, these 
findings may be due to inappropriate use of the shield by many operators. The shield should 
be as close as possible to the patient to stop the scatter at the source for the greatest degree of 
attenuation. 
 
Figure 2.5. Ceiling mounted lead glass with accompanying lead skirt shield and table lead skirts to 
protect the operator in the cardiac catheterisation laboratory further. 
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2.2.2.7 Table lead skirts 
The lower region of the operator receives the most exposure during a procedure. The 
proximity of the X-ray tube to this region leads to increased exposure from leakage radiation 
from the X-ray tube housing and backscattered photons from the patient. Protecting the lower 
truncal region containing the reproductive organs is essential due to their radiosensitivity. 
Wearable aprons provide the majority of this shielding. However, table lead skirts decrease 
the dose even further by over 90% (Donadille et al., 2011, Fetterly et al., 2011). When 
possible, utilising these skirts is very important. However, it may be challenging if the gantry 
is in a steeply angulated position. 
2.2.2.8 Patient Drapes 
Radiation drapes can be placed on top of the patient to stop the scatter radiation that 
contributes to operator dose at the source. For example, the RADPAD® is a commercially 
available solution that is disposable and lead-free which has shown some promise. The 
manufacturer claims a reduction of up to 95% of scatter radiation. Recent independent studies 
indicate that up to 80% dose reduction is possible to the operator during procedures with 
correct placement of the drape (Power et al., 2015, Politi et al., 2012, Simons and Orrison, 
2004). This reduction in dose to the operator is possible without increasing the dose to the 
patient (Iqtidar et al., 2013). These drapes are single use and mostly employed in procedures 
anticipated to require prolonged fluoroscopy and multiple acquisitions.  Other strategies to 
achieve similar outcomes are currently under investigation. 
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2.2.3 Procedural Aspects 
2.2.3.1 Access Site 
While transradial cardiac catheterisation has been shown to reduce bleeding complications 
for the patient compared to the transfemoral approach, it increases operator radiation 
exposure (Brasselet et al., 2007, Mann 3rd et al., 1995, Lange and von Boetticher, 2006, 
Plourde et al., 2015). There is evidence that higher doses are received in left radial access 
procedures (Pancholy et al., 2015). The higher dose may be due to the operator being nearer 
to the X-ray tube (Whitby and Martin, 2014), longer fluoroscopy times and potential 
difficulties in using ceiling mounted shields in this configuration. Access using the 
subclavian approach for device implants exposes the operator to even higher radiation due to 
the proximity of the X-ray tube (Limbacher et al., 1998). The use of additional shielding may 
be required to lessen the increased radiation exposure from different access sites. During 
radial access procedures, the use of a patient drape has been shown to lower operator dose by 
up to 72% in simulations  (Ertel et al., 2012), and combining a larger ceiling mounted shield 
can also lower exposure (Gilligan et al., 2015). 
2.2.3.2 Real-time Operator Feedback 
Feedback regarding patient dose by verbal notification from the radiographer, console 
notifications or through a real-time personal dosimeter during a procedure should assist the 
operator in making modifications to lower intraprocedural dose. Reference air kerma and 
DAP are the most commonly used patient dose burden metrics and lowering patient dose will 
also result in reduced staff exposure. In this context, verbal warnings at regular intervals, for 
example at every 2 Gy reference air kerma, can act as a reminder to the operator that 
exposure is accumulating. However, using patient-based radiation dose metrics to reflect 
operator dose may not be entirely accurate. Real-time personal dosimeters such as the 
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RaySafe i2 (Unfors RaySafe AB, Sweden) device provide information regarding operator 
radiation exposure. These devices are accurate in quantifying the dose (Mangiarotti et al., 
2015, Inaba et al., 2014). A recent study shows that in combination with patient monitoring 
software the feedback provided lowers operator exposure (Heilmaier et al., 2015). However, 
further study is required to show if personal real time dosimeters alone can impact operator 
behaviour to reduce the dose. 
2.2.4 Summary 
Cardiac catheterisation laboratory staff receives no benefit from ionising radiation and efforts 
to reduce scattered radiation at the source are of particular importance. Staff should utilise all 
protective equipment available to them to keep occupational radiation exposure as low as 
reasonably achievable. Reducing the overall patient radiation dose during a procedure will 
lessen the amount of scattered radiation to which staff are subjected and should be a major 
goal. 
The use of radiation protection tools in isolation will not provide optimal protection to staff 
members. However, a combination of instruments as outlined in this review would be most 
effective.  Studies show that combining lead glasses, thyroid collar, apron and table lead 
skirts substantially reduce operator dose (Thornton et al., 2010, Challa et al., 2009, Karadag 
et al., 2013, Kuon et al., 2003, Kuon et al., 2002). With recent evidence showing radiation-
induced injuries occurring in historically non-shielded areas such as the head and neck, it is 
important that radiation safety measures should evolve to include these regions. 
Procedural modifications such as increased beam collimation, lowering fluoroscopic pulse 
rate and increasing operator distance from the x-ray source are also paramount in lowering 
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overall procedure dose. Previous work shows that simply stepping away from the patient 
during cine acquisitions reduced operator dose nine-fold (Jeans et al., 1985). Clinical 
decisions such as vascular access site will also play a vital role in operator radiation dose 
management. However, it is important that diagnostic and therapeutic outcomes not be 
compromised.  
Every practice should find suitable means to reduce operator dose without compromising 
occupational health and safety and procedural outcomes using the principles outlined in this 
paper. It is also important that protective equipment is correctly used to ensure optimal 
radiation protection. To achieve these goals, education, staff training, audit on radiation 
safety awareness and protection is mandatory. 
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Table 2.2. The radiation dose for the operator from common cardiac interventional procedures in µSv from recent literature. 
DCA PCI BV ASDC DES RFA PI DI Year Reference 
2.2 8.8 - - - - - - 2001 
Padovani, R. and C. Rodella 
(Padovani and Rodella, 2001) 
1.8-2.7 1.2 - - - - - - 2003 
Delichas, M., et al. (Delichas et 
al., 2003b) 
- - - - - 1 - - 2003 
Macle, L., et al. (Macle et al., 
2003) 
0.2 0.3 - - - - - - 2004 
Tsapaki, V., et al. (Tsapaki et al., 
2004) 
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- 8.7 - - - - - - 2005 
Tsalafoutas, I.A., et al. 
(Tsalafoutas et al., 2005) 
0.4 0.6 - - - 0.2-0.4 0.3 0.9 2005 
Trianni, A., et al. (Trianni et al., 
2005) 
2.9(R) 1.3 (F) 6.95 (R) 4.1 (F) - - - - - - 2008 
Brasselet, C., et al. (Brasselet et 
al., 2008) 
0.2-38.0 0.17-31.2 - - - 0.24-9.6 2.9-17.4 2.9-17.4 2008 
Kim, K.P., et al. (Kim et al., 
2008) 
* DCA – Diagnostic Cardiac Angiogram, PCI – Percutaneous Coronary Intervention, BMV – Balloon Valvuloplasty, ASDC – Arterial Septal 
Defect Device Closure, DES – Diagnostic Electrophysiology Study, RFCA – Radiofrequency Catheter Ablation, PI – Pacemaker Implantation, 
DI – Cardiac Defibrillator Implantation. 
**R denotes radial artery route and F denotes Femoral artery route.  
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3 Automated Patient Dose Management 
3.1 Introduction 
Radiation dose management plays a key role in managing the risk of radiation-induced side 
effects. As the magnitude of the radiation dose imparted increases, so does the proportional 
risk of side effects. It is thus important to closely monitor the radiation dose associated with 
radiology procedures to determine the safety of the procedure and any expected tissue 
reactions. It would then be advantageous to compile a database of radiation dose received by 
each patient in a medical setting. This data, in the future, could be used to correlate with the 
incidence of side effects to gain a better understanding of radiation-induced side effects from 
medical exposure. This data could also be used to understand better the likelihood of future 
stochastic effects – the evidence for which, while heavily documented in the literature, is 
based on data from atomic bomb survivors and other environmental radiation sources.  
Furthermore, recording the patient dose information in the patient’s medical records at the 
conclusion of each procedure is required by both local and international regulations. The 
recorded information needs to include Reference Air Kerma, Dose-Area Product, fluoroscopy 
times, the number of fluoroscopic images and maximum skin dose (if reported by the 
machine or if there are means of calculating it post procedure). This data is used for patient 
reporting and for quality assurance and audits which drive radiation dose optimisation. 
Given the large volume of fluoroscopically guided procedures undertaken on a daily basis, 
the need for an accurate, and timely reporting it is preferable that the dose management is 
automated. This chapter will present the methods used in this thesis for dose management, 
including the information collated, limitations and any deviations used from current practice. 
Other organisations who are interested in compiling an automated dose management system 
without necessarily resorting to more expensive commercially available products can use this 
information as a blueprint.  
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3.1.1 Digital Imaging and Communications in Medicine 
A standard for handling medical imaging information has existed since 1993 called the 
Digital Imaging and Communications in Medicine (DICOM). Since then the DICOM 
standard has been instrumental in the workflow of hospitals since it is used to produce, store, 
display, process, send, retrieve, query and print medical images as well as derived 
documentation. Another major advantage of the DICOM standard is not only the ability to 
handle imaging but to also embed key information regarding the patient, studies and reports 
in the image headers. 
The DICOM standard outlines the methods by which medical images can be formatted and 
exchanged between medical and non-medical environments. They can be used to transfer 
information between a range of digital imaging devices including to and from a variety of 
imaging sources (e.g. computed tomography, ultrasonography, nuclear medicine and 
magnetic resonance imaging) and processing devices or archives.  It functions as a 
comprehensive standard for the communication of information between computer systems 
and incorporates information on content, structure, encoding and protocols for the transfer of 
pertinent information (Bidgood et al., 1997).  
3.1.2 Radiation Dose Structured Report 
The radiation dose structured report was released as part of the DICOM Standard as 
supplement 94 (DICOM Standards Committee, 2005) and is optimised for fluoroscopically 
guided procedures, with similar protocols for mammography and computed tomography 
released in 2008. The RDSR is created and kept separately to information regarding images, 
which means it will store information about generated images even if they have when 
discarded (e.g. in fluoroscopic runs), unlike DICOM headers which only exist if there is a 
saved image. The RDSR contains data about the patient and examination as well as the total 
dose imparted for the procedure. For fluoroscopically guided procedures it will also include 
technical, geometric and dosimetric information on each irradiation. IEC PAS 61910-1 
defines the compliance levels and specifies the minimum RDSR contents for each level 
(International Electrotechnical Commission, 2007). Both RIS and PACS systems, as well as 
dose management software, have the ability to capture RDSRs since it is a DICOM object 
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like other medical imaging files. Not all PACS systems have support for reading RDSR at a 
user level.  
Each item of code in the DICOM standard RDSR will contain three values - the coding 
scheme designator, the code value and the code meaning. Scheme designators for a DICOM 
value identify which coding scheme has been used to define the term reported. Coding 
schemes that are defined by the DICOM Standard will contain the value “DCM”. Private or 
vendor specific coding schemes, however, will use the value “99” or “L”.  
3.1.3 Radiation Dose Metrics 
Metrics that are important in patient dosimetry are the Air Kerma at the Reference Point and 
the Dose-Area Product; both measured from onboard ionisation chambers. These two metrics 
are key in comparing radiation outputs from different settings, machines and various 
procedures and thus are useful when establishing facility radiation reference levels. However, 
these units are not without their limitations since they only describe the radiation output in air 
from the X-ray tube, rather than radiation imparted in the patient's tissue. A method must 
exist to obtain the more useful metrics such as Incident Air Kerma which would further allow 
the calculation of Entrance Skin Dose and Peak Skin Dose to manage specific patients rather 
than a population (for example, predicting the likelihood of a deterministic effect following 
an extended procedure). 
Geometrical factors must be taken into account to estimate the above values from the 
measured metrics such as Reference Air Kerma and Dose-Area Product. Such factors include 
collimator positioning to understand the size of the irradiated area, gantry beam angles to 
understand the location of the irradiated area on the patient and specific patient geometry 
such as table height and lateral position to correct for the patient’s positioning within the 
beam. 
3.1.4 Current methods 
At the time of writing the majority of radiation dose management is done manually. That is, a 
radiographer is required to enter the data about the dose into the radiology information 
system (RIS) at the conclusion of a procedure. There are manufacturer bound systems 
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available such as the Toshiba Dose Tracking system and the Siemens Care suite as well as 
systems that can support multi vendors such as GE Healthcare DoseWatch, Philips DoseWise 
and Sectra Dose Track. Vendor neutral systems do exist such as the Radimetrics™ and 
INFINITT DoseM, but these systems come at a substantial cost or are limited to higher end 
products in the vendor range and are therefore not widely used. 
3.1.5 Objective 
The purpose of this chapter is to create a vendor-neutral data collection and storage method 
which stores all patient related dose information as well as automating patient skin dose 
calculations. This method will all be developed using open source software allowing 
portability between institutions without any financial restrictions.  
3.2 Methods 
The methods section in this chapter will validate each correction method used within the 
appropriate subsection as well as compare to published literature where relevant.  
3.2.1 Programming Languages Used 
DICOM receipt was handled by the Oldenburger Institut für Informatik (OFFIS) storescp tool 
which is primarily written in C++ (Eichelberg et al., 2004). Python (Zelle, 2004) was the 
primary language used to carry out background processing functions such as parsing RDSR 
data, calculating skin dose and inserting the study into the database.  
The open source scripting language PHP (Yank, 2004), with some calls to Python, make up 
the front end user interface.  Most modern web servers will run the PHP code with little 
modification. As the Relational Database Management System (RDMS) is Microsoft SQL 
server, an additional PHP module was required from Microsoft to interface with it. 
3.2.2 DICOM Receipt 
A program that acts as a DICOM Service Class Provider (SCP) to allow a peer Service Class 
User (SCU) to associate and transfer DICOM files handles DICOM receipt. For this, the 
existing tool storescp from OFFIS was used to listen on port 1112 and store all incoming 
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DICOMs into a spool folder at archive\spool.  The following command line combination was 
wrapped in a service using Non-Sucky Service Manager (NSSM) for persistent configuration: 
tools\dcmtk\bin\storescp.exe +xa -lc 
tools\dcmtk\etc\dcmtk\filelog.cfg -fe .dcm -pm -aet MEDPHYS -od 
archive\spool 11112 
DICOM files build up in the “archive\spool” directory for an additional Python script to loop 
through and process accordingly. This python script is also wrapped with NSSM for it to run 
as a windows service. 
 
Figure 3.1. Diagram of the connection between the modality and the user. 
3.2.3 Data Storage 
The storage database utilises both flat file and relational database. File storage was used to 
store the archive of DICOM files for auditing, further processing at a later stage or to carry 
out real-time calculations on already existing DICOM files. An RDMS Microsoft SQL server 
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was used to stored structured study, series and instance data processed from the flat files, 
used by queries out of various interfaces. Figure 3.2 depicts the database structure is, and 
Figure 3.3 shows the archived folder structure. 
 
Figure 3.2. Database structure used for the storage of patient radiation dose information. 
 61 
 
Figure 3.3. Archive folder structure used for storage of the DICOM files 
archive\<Year>\<Month>\<Day>\<Hour>\<Minute>. 
The Python script discussed in the previous section is responsible for ingesting the studies 
into the database and moving the DICOM files from the “archive\spool” folder into 
appropriate date/time structured folders. Before doing this, the following processing occurs: 
• Ensure integrity of DICOM file 
• Strip image data from set 
• Retrieve basic DICOM metadata 
• Insert DICOM study into database if not already exists 
• Insert DICOM series detail into database if not already exists 
• Insert DICOM instance detail into database – throw Exception if it exists 
• Move DICOM file into “archive\<year>\<month>\<day>\<hour>\<minute>” folder  
Upon finding exceptions, the python script will skip processing and move the file into the 
“archive\error” folder. The exceptions include bad data, duplicate instances and SQL server 
unavailability.  
 62 
At the end of the ingestion process, the study will exist in the database for further processing 
depending on the modality. Additional Python scripts will run to process studies that are not 
yet captured and insert them into the appropriate study_<modality> tables. These scripts are 
setup as a Windows service.  
In the case of XA (X-Ray Angiography) studies the Python script to process these carries out 
the following: 
1. Retrieve outstanding XA studies  
2. Read in all required information 
3. Make dose calculations 
4. Insert into study_xa table 
5. Move to next XA study 
 
Figure 3.4. Example query from the study database using SQL Management Studio 2017. 
3.2.4 Skin Dose Calculations 
To best predict radiation-induced effects following fluoroscopically guided procedures, the 
readily available measurements of reference air kerma must be mathematically corrected to 
account for a patient’s tissue as well as the patient position for each instance of radiation 
exposure. 
3.2.4.1 Patient position correction 
The IEC defines a point that is 15 cm below the isocenter of the gantry towards the X-ray 
tube as the Interventional Reference Point (IRP). Onboard detectors and calculated dose 
measurements must be accurate at this point (International Electrotechnical Commission, 
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2000). This location does not always coincide with the beams incidence on the patient's skin. 
Two methods can be employed to correct for the positioning of the patient. However, both 
approaches rely on vendor compliance with the DICOM SR standard. 
 
Figure 3.5. Location of the IEC interventional reference point of measurement as compared to patient 
skin entrance location and FDA dose measurement point (Balter, 2006). 
Experience indicates that not all vendors will use the DICOM standard in practice. In the 
DICOM Standard, the code 113753 “Table Height Position” and 113752 “Table Lateral 
Position” are important because they define the patient position with respect to the gantry 
isocenter. However, certain vendors set this value to signify the table height distance from the 
floor or use a different reference location rather than the gantry isocenter. Table 3.1 indicates 
the codes needed for patient position corrections. 
If the fluoroscopic machine is a Bi-plane unit, then Table Lateral Position must be accounted 
for as a variable when correcting for the position. The secondary acquisition plane (B plane), 
takes lateral images of the patient, and thus the patient moves horizontally rather than 
vertically in this plane. Hence using table height to correct for patient positioning within this 
plane will not yield accurate results. The Table Lateral Position code provides the user with 
the location of the table across the horizontal plane with respect to the isocenter and is a 
much more accurate value to use when correcting for B plane acquisitions. 
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The majority of acquisitions done in this plane will be at values near the isocenter, since the 
patient must be centred to allow for acquisitions from both planes simultaneously. Should the 
Table Lateral Position be unavailable in the RDSR, it is a safe assumption to correct for the 
patient at the isocenter with an offset for the patient's skin entrance location (approximately 
15cm from the isocenter). The corrected kerma value would then be equal to the reference air 
kerma measurement in the B plane. 
Table 3.1. Values required for geometric correction based on patient positioning with respect to the 
interventional reference point of measurement for air kerma. 
Code Display Definition 
113748 Distance 
Source to 
Isocenter 
Distance from the X-Ray Source to the Equipment C-Arm 
Isocenter (Centre of Rotation). 
113752 Table Lateral 
Position 
Table Lateral Position with respect to an arbitrarily chosen 
reference by the equipment. Table motion towards CRA is positive 
assuming that the patient is positioned supine and its head is in the 
normal position. 
113753 Table Height 
Position 
Table Height Position with respect to an arbitrarily chosen 
reference by the equipment in (mm). Table motion downwards is 
positive. 
 
If the coding scheme designator is DCM, i.e., the DICOM standard, calculate the correction 
factor (CHeight) as: 
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Equation 3.1. The equation used to derive the correction factor for DICOM standard reported 
geometric values. 
!"#$%&',)*+ = -./01234	678934	07	:/7342049 − 150-./01234	07	:/7342049 − ?1@A4	B4.Cℎ0	E7/.0.72 F 
 
If the coding scheme designator is not DCM, then CHeight will be calculated as: 
Equation 3.2. The equation used to derive the correction factor for non-conforming geometric values. 
!"#$%&',G = -./01234	678934	07	:/7342049 − 150?1@A4	B4.Cℎ0	E7/.0.72 F 
 
The numerator accounts for the Air Kerma measurement position, while the denominator 
accounts for the patient positioning with respect to the gantry isocenter. For B plane 
corrections when using a Bi-Plane unit, the value Table Lateral Position should be substituted 
for the Table Height Position. 
3.2.4.2 Air to Tissue absorption factor correction 
The absorption of radiation in air is different to that of tissue. The radiation metric reported 
by the machine is a measure of kinetic energy deposited per unit mass of air. Therefore, a 
correction factor must be applied to account for the differences between patient skin tissue 
and air. 
Johns & Cunningham (Johns and Cunningham, 1983) tabulated the ICRU factors 
(International Commission on Radiation Units and Measurements, 1989) required to convert 
between the air and skin mediums for different beam qualities. The beam qualities between 
stationary and fluoroscopic acquisitions are different because of the added filtration with the 
beam to control patient dose and image quality.  The published table of values from Johns & 
Cunningham was used to formulate an equation that accounts for the different quality beams 
in the two types of acquisitions; fluoroscopic and stationary/rotational. An equation is derived 
using a 2nd degree polynomial regression (Equation 3.3). Table 3.2 indicates the codes 
required for the tissue absorption coefficient equation.  
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Table 3.2. Values required for correction of the tissue absorption factor based on the type of 
acquisition and the peak energy of the X-ray beam. 
Code Display Definition 
113721 Irradiation 
Event Type  
Denotes the type of irradiation event recorded 
113733 KVP Applied X-Ray Tube voltage at the peak of X-Ray generation, in 
kilovolts; Mean value if measured over multiple peaks (pulses) 
Depending on the value in Irradiation Event Type an appropriate fitting parameter should be 
selected from Table 3.3, and calculate the tissue absorption factor (Fskin) as: 
Equation 3.3. The equation used to derive the correction factor for the tissue absorption coefficient 
from the measured air kerma. 
!HI$J = 	K×MNOP 
Where α and β are the fitting parameters found in Table 3.3. 
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Table 3.3. shows the goodness of fit of the coefficients (α, β) used in Equation 3.3, analysed 
using a regression analysis. The results of the regression indicated that the coefficients 
showed a strong correlation (R square > 0.9) for estimating the tissue absorption coefficients 
for both fluoroscopy and acquisitions. Table 3.4 & 3.5 provide a comparison of the tabulated 
air to tissue absorption factors found in the literature and the values obtained using Equation 
3.3. 
Table 3.3. The values of the coefficients used in tissue absorption corrections for the different types of 
acquisitions as well as statistical analysis of goodness of fit. 
Type of Radiation Fluoroscopy Acquisition 
α 0.973 0.993 
β 0.020 0.016 
R square 0.937 0.992 
F 59 491 
Degrees of Freedom (numerator, 
denominator) 
1, 4 1, 4 
P value 0.0015 <0.0001 
 
  
 68 
Table 3.4. Tabulated values from Johns and Cunningham (Johns and Cunningham, 1983) for 
Fluoroscopic beam qualities as compared to the calculated values using the derived equation. 
kVp Tabulated Calculated 
60 1.061 1.062 
65 1.063 1.063 
70 1.065 1.065 
75 1.066 1.066 
85 1.068 1.068 
95 1.069 1.070 
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Table 3.5. Tabulated values from Johns and Cunningham (1983) for Acquisition beam qualities as 
compared to the calculated values using the derived equation. 
 
 
3.2.4.3 Backscatter correction 
As X-rays traverse patient tissue, two major photon interactions take place, Compton scatter 
and photoelectric absorption (discussed in detail in Chapter 1). Apart from the dose initially 
absorbed at the patient skin level, there is a significant backscatter of photons towards the 
patient skin, which contributes to a greater dose to the skin. This value must be accounted for 
when converting from the entrance dose to the skin dose as it can add as much as 40% more 
dose in the diagnostic X-ray range. 
kVp Tabulated Calculated 
60 1.056 1.056 
65 1.058 1.058 
70 1.059 1.059 
75 1.061 1.061 
85 1.063 1.063 
95 1.066 1.066 
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The incidence of Compton scattering is proportional to the beam energy, which means the 
kVp and filtration will have an effect on the amount of scattering within the patient. 
Furthermore, the greater the volume of tissue imaged, or the field size selected, the greater 
the number of scattering interactions within the patient.  Thus, the field size must also be 
known for the correction.  
By determining the ratio of air kerma at a set location with and without a patient or phantom 
in the beam for varying field sizes and beam qualities, one can account for backscatter. The 
dose with the phantom or patient will be greater by 20-40% within the diagnostic range. 
These values are determined both experimentally and through simulations in the literature for 
different beam qualities and X-ray field sizes. 
The backscatter factors (BSF) within the diagnostic range are obtained from Petoussi-Henss 
et al. for varying field sizes and beam energies (Petoussi-Henss et al., 1998). This table of 
values was used to formulate equations that account for both field size and beam quality. A 
2nd degree polynomial regression of the backscatter values is undertaken to derive an 
equation for this software (Equation 3.4, 3.5 and 3.6). Table 3.6 indicates the codes from the 
RDSR required for the backscatter correction factor.  
Table 3.6. The values required from the RDSR for the application of the backscatter factor, based on 
field size and beam energy. 
Code Display Definition 
113733 KVP Applied X-Ray Tube voltage at the peak of X-Ray generation, in 
kilovolts; Mean value if measured over multiple peaks (pulses) 
113790 Collimated 
Field Area 
Collimated field area at image receptor. Area for compatibility 
with IEC 60601-2-43. 
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If the Collimated Field Area is less than or equal to 250 cm2, estimate the BSF as: 
Equation 3.4. The equation to calculate the correction factor for backscatter in a 10x10 cm2 irradiated 
field size. 
Q6!RSS = K×MNOP 
If the Collimated Field Area is between 250 cm2 and 650 cm2, estimate the BSF as: 
Equation 3.5. The equation to calculate the correction factor for backscatter in a 20x20 cm2 irradiated 
field size. 
Q6!TSS = K×MNOP 
If the Collimated Field Area is greater than 650 cm2, estimate the BSF as: 
Equation 3.6. The equation to calculate the correction factor for backscatter in a 30x30 cm2 irradiated 
field size. 
Q6!USS = K×MNOP 
Table 3.7 lists the fitting parameters α and β for the appropriate area when matching the value 
harvested from the Collimated Field Area. 
Table 3.7. shows the goodness of fit of the coefficients (α, β) used in Equations 3.4, 3.5 and 
3.6, analysed using a regression analysis. The results of the regression indicated that the 
coefficients showed a strong correlation (R square > 0.9) for estimating the BSF for the 
different field sizes. Table 3.8 provides a comparison of the tabulated values found in the 
literature and the values obtained using the above equations. 
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Table 3.7. The coefficients required for the backscatter factor for the different field sizes as well as 
statistical analysis of goodness of fit. 
Field Size (cm2) 100  400 900 
α 0.851 0.651 0.637 
β 0.115 0.175 0.182 
R square 0.986 0.986 0.991 
F 409 412 669 
Degrees of Freedom (numerator, 
denominator) 
1, 6 1, 6 1, 6 
P value <0.0001 <0.0001 <0.0001 
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Table 3.8. Tabulated values of backscatter factors from Petoussi-Henss et al. 1998  (Petoussi-Henss et 
al., 1998) for different beam energies and field sizes as compared to the calculated values using the 
derived equation. 
Field Size (cm2) kVp Literature Calculated 
100 50 1.25 1.27 
 60 1.28 1.29 
 70 1.34 1.32 
 80 1.36 1.34 
 90 1.37 1.35 
 100 1.38 1.37 
 110 1.35 1.39 
 120 1.40 1.40 
400 50 1.27 1.29 
 60 1.32 1.33 
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 70 1.40 1.37 
 80 1.43 1.40 
 90 1.45 1.43 
 100 1.46 1.46 
 110 1.43 1.48 
 120 1.51 1.50 
625 50 1.28 1.30 
 60 1.32 1.34 
 70 1.40 1.38 
 80 1.44 1.41 
 90 1.46 1.44 
 100 1.48 1.47 
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 110 1.44 1.49 
 120 1.53 1.52 
 
3.2.4.4 Table and Cushion Attenuation Correction 
Another factor to account for is the attenuation provided by the patient table and cushion. A 
detector placed near the exit port of the tube directly measures air kerma. Thus, the 
measurement of radiation exposure is previous to any interactions that occur when the beam 
traverses the patient table and cushion. A correction factor is commonly directly measured 
and used to account for this attenuation. Directly measuring the correction factors for the 
different X-ray beam characteristics, as well as several table and cushion thickness 
combinations, is time-consuming and cumbersome. A secondary aim of this chapter is to 
derive a mathematical method to estimate the table and cushion coefficient for varying filter 
and table and cushion thickness. 
A Shimadzu Trinias F12 using a cardio 10 pps protocol with 200mA was used to collect 
directly measured half value layer and Air Kerma measurements on a Piranha Dose probe. 
The total filtration in the beam, the sum of the added and inherent, was 2.5 mm Al and 0.01 
mm Au. Measurements were taken at ten kVp intervals from 60 to 120 kVp with and without 
the table and cushion. The table and cushion are equivalent to 0.8Al and 0.2Al at 70 kVp 
respectively. The attenuation factor was the ratio between the values measured with and 
without the table and cushion, at each set kVp. 
A software package called Xertex 5.0 was used to generate the X-ray spectrum and collect 
simulated values through inputting the same filtration in the beam (Mclean, 2004). Tungsten 
is selected as a target material with an angle of 12 and a 3-phase high voltage waveform. The 
dose rate in the air is compared to the added filtration when the table and cushion are within 
the beam. 
 76 
A Bland-Altman (Figure 3.6) analysis was performed to compare percentage difference 
between measured and simulated values, as compared to the average table and cushion 
coefficients. Comparison of the measured values to the simulated values resulted in an 
average discrepancy of -1%. This bias can be corrected for in the final calculation for table 
and cushion attenuation. However, a mean discrepancy of -1% and the small limits of 
agreement between -1.6% and -3.6% at a 95% confidence interval prove that the two 
methods give practically equivalent results. All the values lie within 1.96 standard deviations 
of the mean. The magnitude of the average difference shows a tendency to increase with a 
reduction in energy of the beam. At low energy beams using the simulation data and table 
and cushion coefficients calculated the difference between a directly measured value and the 
simulated value increases to -2.5% at 60 kVp as compared to 0.6% at 120 kVp. 
 
Figure 3.6. Bland-Altman plot: percentage difference between directly measured coefficients and 
simulated table and cushion coefficients. Dotted lines indicate the 95% confidence intervals and the 
solid line indicates the bias. 
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Following the validation using the Shimadzu system, the Xertex software package was then 
used to simulate the correction factors for some of the filtration and table and cushion 
combinations used by other manufacturers (Figure 3.7 & 3.8). A power regression was 
performed to find an equation and coefficients to predict the table and cushion attenuation at 
varying kVp based on the collected data. A semi-log transformation was done to obtain the 
data in a linear form to allow a linear regression analysis. Table 3.9 indicates the codes that 
are required to be harvested from the RDSR to estimate the transmission through table and 
cushion. 
 
 
Figure 3.7. Table and cushion transmission factors for table and cushion with an equivalence of 1mm 
Al at 70 kVp. 
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Figure 3.8. Table and cushion transmission factors for table and cushion with an equivalence of 2mm 
Al at 70 kVp. 
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Table 3.9. The values required from the RDSR for application of the Table and cushion attenuation 
factor based on kVp and filtration. 
Code Display Definition 
113733 KVP Applied X-Ray Tube voltage at the peak of X-Ray 
generation, in kilovolts; Mean value if measured over 
multiple peaks (pulses) 
113757 X-Ray Filter 
Material 
X-Ray absorbing material used in the filter 
113758 X-Ray Filter 
Thickness 
Minimum 
The minimum thickness of the X-ray absorbing material used 
in the filters. 
The fitting parameters are deduced from regression to estimate the transmission factor as a 
function of kVp and applied to the following equation: 
Equation 3.7. Equation used to estimate the table and cushion attenuation correction factor from tube 
potential and filtration 
? = K×MNOF 
Where α and β are the fitting parameters found in Table 3.10 and 3.11. 
An exception is included in the code for Primary Angles less -90 degrees and greater than 90 
degrees. These angles do not need the application of table and cushion attenuation corrections 
due to the tube location being above the patient, which means the patient’s skin will be in 
direct line of the X-ray beam without transmission through the table or cushion. 
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Table 3.10. Coefficients for 1mm Al equivalence table and cushion equation for the varying filtrations as well as statistical analysis of goodness of fit. 
 1.5Al+0.3 Cu 1 Al 1.5Al+0.6Cu 2Al+ 0.1Cu 1Al+ 0.01Au Cu 0.9 Cu 0.2 Cu 0.5 No added filtration 
α 0.568 0.257 0.643 0.457 0.357 0.675 0.492 0.616 0.652 
β 0.101 0.244 0.078 0.140 0.185 0.069 0.127 0.086 0.076 
R square 0.994 0.994 0.971 0.995 0.996 0.991 0.992 0.992 0.995 
F 867 841 170 919 1223 519 613 586 962 
DFn, DFd 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 
P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
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Table 3.11. Coefficients for 2mm Al equivalence table and cushion equation for the varying filtrations as well as statistical analysis of goodness of fit. 
 1.5Al+ 0.3 Cu 1 Al 1.5Al+0.6 Cu 2Al+ 0.1 Cu 1Al+ 0.01 Au Cu0.9 Cu0.2 Cu0.5 No added filtration 
α 0.329 0.083 0.416 0.220 0.143 0.457 0.252 0.383 0.043 
β 0.198 0.447 0.155 0.271 0.348 0.138 0.247 0.170 0.565 
R square 0.994 0.988 0.990 0.992 0.996 0.970 0.996 0.984 0.997 
F 793 382 490 596 1223 162 1160 315 1880 
DFn, DFd 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 1, 5 
P value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
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3.2.4.5 Accumulated Skin Dose 
The correction factors are combined to estimate the patient accumulated skin dose from 
reference air kerma (Equation 3.8). Table 3.12 indicates the codes required from the RDSR 
that measures the dose at the reference point for each exposure instance. The reference air 
kerma for each instance (irradiation event) then needs to be corrected with the corresponding 
correction factors calculated above and then summed to calculate the total dose. The total 
dose is estimated using the following equation: 
Equation 3.8. The equation used to estimate the absorbed dose to the skin from the calculated 
correction factors and the reference air kerma measured in Gy. 
!"#$% = '()×+,-$./0×+"#$%×12+×3%$  
Where RAK is the Reference Air Kerma harvested from the RDSR (measured in Gy), Fhieght 
is the patient position correction factor, Fskin is the tissue absorption coefficient, and BSF is 
the backscatter factor. 
Table 3.12. Values required to be harvested from the RDSR to estimate the absorbed dose to the skin. 
Code Display Definition 
113738 Dose (RP) Dose applied at the Reference Point (RP). 
3.2.4.6 Peak Skin Dose 
An open source software for the peak skin dose estimation exists in development named 
openSkin (Cole, 2016). This software is modified as part of this project to include the 
backscatter corrections, table and cushion transmissions and tissue absorption coefficients 
derived above. The methods for extracting the data from the RDSR and DICOM headers are 
developed in this thesis. However, the remainder of the peak skin dose code is kept in its 
original form and is not produced as part of this thesis. 
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3.3 Results 
A system was developed to collect all radiation dose information following fluoroscopically 
guided interventions in the cardiac catheterisation laboratory. This system was also 
developed to automate all skin dose calculations following the procedure and to warn 
operators if patients are likely to reach the threshold for any adverse skin reactions. The 
feedback surrounding the radiation dose to the patient is used as the basis for radiation dose 
optimisation and educational talks.  
3.3.1 User Interface 
The core of the web interface component allowed users to review studies as they arrive and 
are processed. There are two main parts of the web interface: 
1. DICOM Archive – allowed users to review all incoming DICOM studies before being 
handled by Python based modality processor scripts. 
2. Modality groups – allowed users to create and review their views of studies from 
study_<modality> categorizations. 
On selecting the “DICOM Archive” option (Figure 3.9), a user is presented with the last 30 
days of all DICOMs that have entered the database. The user can select a different date range 
and drill down into the respective series and instances. 
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Figure 3.9. Interface view of DICOM archive. 
To create a specific modality group view, the user clicks on “Modify Groups” in the side 
panel. One can then select to create a new view or update existing. There are then options to 
enter a friendly name, select a modality, display order and a criterion to restrict the modality 
group view to (Figure 3.10). 
 
Figure 3.10. Modifying modality groups that appear in the side panel. 
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The modality group then appears in the user to select the case view for the set of studies as 
well as medians and optimisations (Figures 3.11 & 3.12). 
 
Figure 3.11 – Interface view of cases of modality group “Cath Lab.” 
 
Figure 3.12 - Interface view of medians of modality group "Cath Lab." 
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The user also can work with the database directly through Excel to more easily manipulate 
and filter data without having to use SQL queries or lower level programming languages. 
Excel allows the user to import data from SQL Server as shown in Figure 3.13. 
 
Figure 3.13 – Connecting to SQL Server using Microsoft Excel 2016. 
After the connection has been established and range provided for import the user can 
manipulate the data like any other spreadsheet as well as refresh directly from the database as 
shown in Figure 3.14. 
 
Figure 3.14 – Data as it appears in Excel after connection setup 
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3.3.2 Limitations  
One of the major limitations of relying on the RDSR for radiation dose calculations is that 
there is no manufacturer wide standard coordinate system for patient geometry. Furthermore, 
although DICOM standards exist relating to the dosimetry information provided in the 
RDSR, manufacturers may choose to encode the values with different units of measurement, 
i.e. mGy.cm2 rather than dGy.cm2. The non-standard units of measurements will lead to 
errors if not corrected for in the code for a specific machine. 
Another major limitation is the accuracy of the reported metrics within the RDSR or DICOM 
headers, as discussed in Chapter 4, which could lead to errors in skin dose calculations. 
Additionally, the uncertainties in reported values make it problematic when comparing the 
same procedure on different machines. 
The correction of patient position in non-orthogonal angles is prone to error. The patient 
entrance point in the Posterior-Anterior (PA) or Lateral planes can easily be accounted for 
however once the C-arm angles deviate away from these locations the patient habitus changes 
and the source to patient distance correction may have some errors. 
3.4 Conclusion 
The sheer load of radiological interventions in modern medicine ensure a manual process of 
dose management is cumbersome, time-consuming and error-prone. The need for storing 
patient dose records for regulatory purposes and the introduction of RDSR has facilitated the 
growth of automated dose management programs. Automating the data collection directly 
from the modality ensures the radiation exposures to the patient is stored accurately and 
promptly in the patient history.  
This chapter developed a system that enables data collection to be used in the chapters to 
follow. Additionally, code to estimate the accumulated skin dose which allows for the 
prediction of tissue reactions following the procedure was developed. This process enabled 
immediate communication with operators following high radiation dose cases and complex 
procedures, which is used as an educational tool and a driver for dose optimisation as 
presented in Chapter 6.  
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4 Accuracy of Reported Metrics 
4.1 Introduction 
Accurate dose monitoring and reporting is an important element in patient and staff radiation 
safety management. The operator must be able to reassess the patient benefit against risk 
during the procedure and also review the patient dose post procedure to continually optimise 
techniques that lead to a lower dose (Wagner et al., 1994). Any sources of error in the 
calibration of the dose monitoring equipment may lead to inaccurate dose information. The 
effects of field size, beam geometry and table position are limitations to the suitability of 
using both dose area product and reference air kerma values as skin dose surrogates. Jones 
and Pasciak reviewed skin dose calculation for fluoroscopically guided procedures and 
provided methods for estimating the dose from known parameters (Jones and Pasciak, 2011). 
Chapter 3 presents methods to automatically collect the data required for skin dose 
estimation, and the use of software to automate the calculations from given values in the 
DICOM headers. However, the calculations can only be as accurate as the information that is 
provided by the unit.  
Currently accepted methods to monitor radiation dose delivered to the patient during a 
procedure are the dose-area-product (DAP) or reference air kerma, of which the latter has 
been shown to correlate best with peak skin dose (Fletcher et al., 2002). Determination of the 
reference air kerma is from an ionisation chamber within the X-ray tube housing calibrated at 
a fixed measurement point. This point is known as the Interventional Reference Point (IRP), 
defined by the IEC as 15 cm towards the X-ray source from the isocenter (International 
Electrotechnical Commission, 2000).  
While operating at the IRP is desirable - since it would provide a reasonable indicator of 
entrance skin dose- it is not always possible. Although deviating from this point does not 
affect the accuracy of the machine displayed air kerma at the IRP, it provides a misleading 
estimate of patient entrance skin dose (Balter, 2006). Furthermore, reference air kerma is 
calibrated under a specific set of conditions that differ between manufacturers, outside of 
which the displayed dose may be subject to inaccuracy (Chida et al., 2011). Hence when 
deviating from this point or calibration conditions, the operator should be made aware that 
using the reference air kerma as a measurement of patient skin dose is misleading. It has been 
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the authors’ experience that misunderstanding of the difference between dose quantities - e.g. 
air kerma, entrance skin dose and peak skin dose - is prevalent. The outcome of this 
misunderstanding is that radiographers, cardiologists and radiologists frequently substitute 
reference air kerma for patient skin dose. 
The corrections discussed in Chapter 3 need to be applied post procedure to predict the risks 
more accurately. Routine checks of the values used in the corrections such as field size, table 
height, and SID reported in the DICOM headers are seldom done. Whereas validation of the 
displayed reference air kerma and DAP is more commonplace during equipment servicing, it 
is still not a necessary quality control process in many regulations. This chapter aims to 
validate the accuracy of DICOM values that are used in skin dose calculations and to identify 
metrics that may require the use of correction factors to enable accurate skin dose estimates. 
A secondary aim of this chapter is to recommend testing intervals for metrics that may 
deviate from manufacturer specification over time. 
4.2 Methods 
Three different fluoroscopy units at the Austin Hospital (Austin Health, Heidelberg, Victoria) 
are investigated for the accuracy of the parameters that are required to make an accurate skin 
dose calculation. The units tested were: Phillips Allura Xper FD20 (SN: 65314; Royal 
Phillips Electronics, Amsterdam, the Netherlands), Siemens Artis Zee (SN: 153247; Siemens 
AG, Erlangen, Germany), and Shimadzu Safire (SN: 26BZ0042; Shimadzu Corporation, 
Kyoto, Japan. The detector used for the direct measurements is the Piranha Dose Probe R100 
(SN: 0809288; RTI Electronics, Mölndal, Sweden) independently calibrated in 2015. The 
Phantom used in this experiment was a 30 x 30 cm polymethyl-methacrylates material 
(PMMA) with a 20cm thickness to simulate the abdominal region of an adult patient. All 
units were compliance tested before the commencement of the project according to Radiation 
Safety Standard: Fluoroscopy X-ray Equipment (2007) published by the Victorian 
Department of Health (Department of Health and Human Services, 2007). 
4.2.1 Table Height 
The table height measurements were done directly using a tape measure and compared to 
displayed values and values in the DICOM headers. Three points were measured, one near 
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the maximum height of the table, one in the middle height and one at the lowest possible 
height. A 70kg adult male then sleeps on the table to apply a downward force, and the 
measured and displayed table height recorded.  
4.2.2 Source to Image Distance 
The source to image distance measurements were taken directly using a tape measure. The 
values recorded were compared to the displayed values and the DICOM headers. 
4.2.3 Field of View 
Field of view measurement was obtained using a CR cassette by placing it on the flat panel 
detector. An image was taken at each different field of view setting with all collimation 
removed from the beam. After the cassette was processed in a CR reader, the area was 
calculated using the measuring tool on OsiriX DICOM Viewer Version 7 (2015). The 
calculated value was then inverse square law corrected for the distance between the CR 
cassette and the detector elements in the flat panel detector. The values were compared with 
the selected FOV size and the calculated FOV size using the shutter locations in the DICOM 
headers.  
4.2.4 Air Kerma and DAP 
A solid-state detector was placed at 15 cm away from the isocenter towards the X-ray tube. 
The table and cushion were removed from the beam by rotating the gantry laterally and 
placing the detector in a foam box (Figure 4.1). The recorded values were compared to 
displayed and DICOM header values. 
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Figure 4.1. Foam box created to place the detector at 30 cm from the flat panel detector. 
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The detector was then removed and replaced by a CR cassette to measure the field size at the 
same location to calculate the DAP. The area was calculated in the same manner as the field 
of view described above. Once the area is obtained, the DAP was calculated by multiplying 
the air kerma and the exposed field size. These values were compared to the displayed and 
DICOM header values.  
4.3 Results 
Tables 4.1 to 4.3 show that the table height and source to image distance (SID) do not vary 
much between manufacturers or when patient weight is added. The greatest difference 
measured for table height is 4 cm (5%) for the Shimadzu unit. Following the addition of 
patient weight, the table height changed by less than 1% compared to the displayed value. 
The source to image distance is accurate on every system.  
Table 4.4 illustrates the results of the measured, DICOM (FOV) and DICOM (shutter) values 
for the field of view. Tables 4.5 and 4.6 compare the air kerma at the IRP and the DAP 
values. 
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Table 4.1. The measured unweighted table height compared to the DICOM harvested table heights. 
Manufacturer Location Measured (cm) Displayed (cm) Difference (cm) 
Siemens Maximum 120 120 0 
Centre 90 90 0 
Minimum 80 80 0 
Philips Maximum 107.5 107.5 0 
Centre 87 87 0 
Minimum 80 80 0 
Shimadzu Maximum 120.5 120 0.5 
Centre 90 87 3 
Minimum 83 79 4 
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Table 4.2 - The measured table height (weighted) compared to the DICOM harvested table height. 
Manufacturer Unweighted (cm) Weighted (cm) Displayed (cm) Difference (cm) 
Siemens 80.2 79.4 80.2 0.8 
Philips 87 86.5 87 0.5 
Shimadzu 87 86.5 90 0.5 
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Table 4.3 - The measured source to image distance relative to the DICOM harvested source to image 
distance. 
Manufacturer Measured DICOM Difference (%) 
Siemens 120 120 0 
90 90 0 
Philips 120 120 0 
90 90 0 
Shimadzu 115 115 0 
90 90 0 
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Table 4.4 - The comparison between the displayed field of view, reported shutter locations and 
measured field of view. 
Manufacturer Measured Area (cm2) DICOM (FOV) (cm2) DICOM (Shutter) (cm2) 
Siemens 884.4 882.1 868.8 
468.7 512.0 491.1 
235.6 242.0 248.2 
64.6 60.5 61.9 
Philips 519.1 480.5 484.7 
134.6 112.5 121.4 
Shimadzu 603.7 519.8 489.2 
424.4 361 362.8 
332.0 231.04 235.9 
234.3 129.96 133.9 
 97 
Table 4.5 - The measurement of air kerma at the reference point of each unit as compared to the 
DICOM harvested reference air kerma. 
Manufacturer Measured (mGy) Unit (mGy) Difference (%) 
Siemens 0.02 0.02 -3 
Philips 1.97 2.00 1 
Shimadzu 0.79 0.77 -3 
 
Table 4.6 - The measurement of DAP compared to the DICOM harvested DAP values. 
Manufacturer Measured (µGy.m2) Unit (µGy.m2) Difference (%) 
Siemens 0.35 0.36 3 
Philips 95.68 103.82 8 
Shimadzu 12.47 11.51 -8 
 
  
 98 
4.4 Discussion 
The patient position within the beam is a major component in geometric corrections to 
calculate the patient dose. Two values which impact this correction are the table height and 
SID. As can be seen in Table 4.1 results show that the displayed table height is not always an 
accurate representation of the actual table position. The maximum deviation was 4 cm greater 
than the displayed value. This number may result in an overestimation of the dose by up to 
15% due to the inverse square law. The age of the machine with the largest discrepancy was 
nine years since installation which leads us to believe that age may have a factor to play in 
the accuracy of the table height. We, therefore, recommend that the table height is measured 
directly on acceptance and then again, every subsequent two years. This frequency ensures 
that any geometric corrections that are made take into account the actual patient position 
within the beam are accurate. The effect of patient weight on the displayed table height 
showed a deviation between 5 and 8 mm when a 70kg patient was on the patient bed. This 
magnitude of discrepancy would not affect the dose calculations dramatically. 
The other factor that plays a role in geometric corrections is the SID. The direct measurement 
of SID as compared to what is displayed showed no deviation no matter the manufacturer or 
age of the system. We, therefore, recommend that this value be tested only upon acceptance 
and only after that when any deviation is suspected.  
The displayed FOV does not take into account added collimation and shutter locations. Thus 
it can be expected that there would be a discrepancy between the displayed value and the 
calculated value based on shutter location and the true measured value. Table 4.4 shows that 
the values are in fact quite dissimilar, with the largest difference occurring on the oldest unit. 
The values measured are expected to be more alike the values calculated from the shutter 
location rather than the selected FOV. However, this is not always the case. At times the 
shutter location is closer to the true measured value than the selected FOV size value, and at 
other times it is more inaccurate as can be seen in Figure 4.2. 4.3 and 4.4. However, we still 
recommend that the shutter locations be used to calculate the field size rather than the 
selected FOV. The shutter location will take into account any collimation the operators use 
while acquiring the image. Again, the older system showed the most discrepancies, and we 
believe that the difference is worse the older the machine. Based on the differences between 
the field sizes, we recommend direct measurement of the irradiated field at each FOV at a 
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frequency of 2 years. This value has large implications on the patient dose as well as 
determining the overlapping beam entry locations on the patient’s skin when assessing peak 
skin dose.  
 
 
Figure 4.2. Percentage discrepancy from the directly measured irradiated field size for the Siemens 
unit. 
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Figure 4.3. Percentage discrepancy from the directly measured irradiated field size for the Philips 
unit. 
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Figure 4.4. Percentage discrepancy from the directly measured irradiated field size for the Shimadzu 
unit. 
The accuracy of the air kerma and DAP are recommended to be within 30% by the 
manufacturers of the equipment tested at this hospital. Operators manipulate certain 
technique factors during the procedures based on the accumulated reference air kerma or the 
DAP to lower patient dose. Furthermore, radiographers assisting the operators will alarm the 
operators when certain threshold doses are received. Routine checks of this value are 
therefore paramount. Depending on the technology used in the fluoroscopic machines the 
detectors can be tested and calibrated to within a tolerance of 15%. Checking of this value at 
yearly intervals is recommended. Knowing the manufacturer calibration technique will 
ensure that the checks are as accurate as possible. Some manufacturers use their reference 
points, and not the IEC recommended values (Chida et al., 2011). Also, some manufacturers 
will calibrate the detector with table and cushion in the beam while others will not.  
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Quality assurance (QA) programs should take into account the values measured in this 
chapter that may impact dose calculations. Table 4.7 summarises the recommended tolerance 
and frequency of checks for each value that is related to calculating an accurate patient skin 
dose. Consideration to the limited accuracy of calibration due to external factors plays a role 
in the magnitude of tolerance levels. For example, an ionisation chamber is used to measure 
DAP and reference air kerma. Ionisation chambers have different responses to varying 
energies of the beam as well as temperature and pressure dependencies thus a higher 
tolerance is allowed as compared to distance values that are only affected by the uncertainties 
of the measurement device. The frequency intervals were determined based on the author's 
experience of drifts in accuracy based on the age of the machine tested. The accuracy as a 
function of unit age is a potential area for future investigations. Table 4.7 also indicates the 
effort required to undertake each measurement. These measurements can be grouped together 
to shorten the time necessary to finish testing each unit. For example, the measurement of 
shutter locations, DAP and air kerma can all be done using the same acquisitions. 
The difference between the measured and displayed value is used to derive correction factors. 
This factor will allow for a more accurate skin dose estimate as well as providing a reportable 
error range for calculations or reported values.   
 103 
Table 4.7. Recommendations on tolerance levels and frequency of testing for DICOM header 
information used in patient dose management. The effort required regarding time is approximated 
based on the author's experience of doing each task separately. 
Value DICOM TAG Frequency Tolerance 
(%) 
Effort 
required 
(minutes) 
Distance source to 
patient 
0018,1111 2 years 5 10 
Distance source to 
detector 
0018,1110 On acceptance 5 10 
Shutter Locations 0018,160(2,4,6,8) 2 years 15 30 
Reference air kerma 0040,8302 1 year 15 30 
Dose area product 0018,115E 1 year 15 30 
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4.5 Conclusion 
The use of DICOM tags and structured dose reports for patient dose management is 
becoming more commonplace. The results from this chapter indicate the need for regular 
checks on DICOM values that are used to calculate patient dose. Common sources of error 
are the displayed dose, and the field size, as well as the table height with age. We recommend 
that each facility include DICOM value checks into their routine QA and correction factors 
are derived to account for any inaccuracies.  
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5 Ultra-Low Pulse Rate Fluoroscopy 
5.1 Introduction 
The coronary angiogram (CA) is a powerful diagnostic tool to investigate coronary artery 
disease. The radiation dose associated with a CA procedure is typically 5-10 mSv which is 
similar to a computed tomography scan (Hart and Wall, 2002). Radiation exposure may 
present a risk of carcinogenesis to the patient during their lifetime (Beir VII, 2006). 
Furthermore, the high radiation dose absorbed by the skin in a large patient or a during a 
lengthy procedure introduces the risk of skin tissue reactions, ranging from transient 
erythema to permanent damage requiring surgical intervention (Balter et al., 2010). Both the 
stochastic (associated attributable carcinogenesis) and deterministic (tissue reaction severity) 
effects are related to cumulative radiation dose. Moreover, the X-rays scattered from the 
patient exposes staff in the catheterisation laboratory to ionising radiation. Previous studies 
have suggested an occupational risk to staff with potential for development of posterior lens 
opacities (Ciraj-Bjelac et al., 2010) and brain and neck tumours (Roguin et al., 2013). 
Consequently, efforts need to be made to keep the radiation dose as low as reasonably 
achievable during the procedure, which would decrease any potential risk for staff and 
patients. 
Fluoroscopy is necessary to perform a coronary angiogram to guide all aspects of the 
procedure with a typical pulse rate of 10-15 pulses per second (pps).  Also, coronary artery 
cine acquisitions are typically performed at 10-15 frames per second (fps) to image the 
moving heart effectively. Mainly due to the high pulse rates and frame rates during a routine 
CA procedure, high radiation doses are delivered as compared to other diagnostic X-ray 
procedures. Utilising the accepted historical pulse rate standard of 10-15 pps may not be 
essential for adequate imaging.  
Significant dose optimisation is possible by utilising lower pulse rates during fluoroscopy 
runs. Reduction in pulse rate from the standard 15 to 7.5pps can result in a significant 
decrease in radiation dose (Schneider et al., 2015, Seiffert et al., 2015, Hansen et al., 2016, 
Plourde and Bertrand, 2017). However, there is no data in the clinical setting which addresses 
the impact of further reductions in pulse rate below 7.5 pps. A potential disadvantage in using 
lower fluoroscopic pulse rates relates to the lower temporal resolution with image ghosting 
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and a lack of smooth cadence to the fluoroscopic run. These degrading effects have the 
potential to impede the procedure and place a limit on minimum pulse rates achievable. 
This chapter examines of the feasibility of using ultra-low pulse rate fluoroscopy (3pps) 
during diagnostic transfemoral CA in an adult population.  The following research questions 
are investigated:  
1. Does the 3pps setting provide adequate temporal ‘clarity’ to the operator? 
2. Does the 3pps setting lead to longer fluoroscopy time to compensate for degraded images? 
3. Is there a significant net reduction in radiation dose when utilising the 3pps setting?  
5.2 Methods 
A retrospective study is undertaken on patients requiring routine transfemoral CA in a well-
established cardiac catheterisation laboratory. Three cardiologists participated, all with 
greater than ten years’ experience in diagnostic and interventional cardiac catheterisation. 
One cardiologist used a fluoroscopic rate of 3 pps while the other two used 10 pps. The CA 
cases are selected from 150 consecutive studies (50 per operator) conducted between 
September 2014 and August 2015. The two operators who used 10 pps acted as control 
groups. Two control groups were chosen to lower the probability of falsely detecting a 
difference based on different operator technique.  
The angiography system used was a single plane Siemens Artis Q Floor 2014 (Siemens 
Healthcare, Forchheim, Germany). The modification of the standard noise reduction 
algorithms and frame averaging functions were required in the 3 pps fluoroscopy protocol to 
ensure sufficient temporal resolution. All three cardiologists used a cine acquisition frame 
rate of 10fps. Standard radiation dose saving measures are employed by all operators 
including low dose rate settings. Primary data collected for each group included total 
accumulated dose area product (DAP), reference air kerma (RAK), and fluoroscopy time 
(FT). Secondary data is collected for the number of cine stored acquisitions, vascular access 
site and patient characteristics including body mass index and gender. 
The data were analysed for statistical differences between the DAP, reference air kerma and 
fluoroscopy time when grouped by the operator using one-way analysis of variance 
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(ANOVA) with post hoc analysis using Tukey's ‘Honest Significant Difference’ (HSD) 
method. Data that did not conform to a normal distribution was analysed using the Kruskal- 
Wallis test with a Bonferroni correction for post hoc analysis. Categorical data were 
compared using the chi-square test. The significance threshold is set at 0.05. Statistical 
analyses were performed using R version 3.3.1 with the Rcmdr package version 2.3-2. 
5.3 Results 
Table 5.1 summarises the patient characteristics, and Table 5.2 summarises the procedural 
characteristics. There was a statistically significant difference in FT values between the 
different operators (p <0.001) with 2.2 mins for Operator A, 1.9 mins for Operator B and 2.6 
for Operator C. A posthoc analysis showed that there was a statistically significant difference 
for FT between Operator A and C (P=0.018; Figure 5.3), however, no significant difference 
is detected between Operator A and B. 
Based on a survey, operator A was able to accomplish all cases, i.e. locate and catheterise 
both coronary arteries and enter the left ventricle using 3pps fluoroscopy to acquire coronary 
angiograms adequate for clinical diagnostic purpose without deviation from the protocol.  It 
is noted that a short transition phase was required for the eye to adjust to the lower temporal 
resolution of fluoroscopic images.  
There was a statistically significant difference in DAP values between operators (P<0.001), 
with a mean rank DAP value of 6.34 Gy.cm2 for Operator A (3 pps), 9.72 Gy.cm2 for 
Operator B (10 pps) and 15.02 Gy.cm2 for Operator C (10 pps). A posthoc analysis showed 
that there was a statistically significant reduction in DAP between Operator A and each of 
Operators B and C (P<0.001; Figure 5.1). 
Finally, there was a statistically significant difference in RAK values between the different 
operators (p <0.001), with a mean rank RAK value of 101 mGy for Operator A, 170 mGy for 
Operator B and 236 mGy for Operator C. A posthoc analysis showed that there was a 
statistically significant reduction in RAK between Operator A and each of Operators B and C 
(P<0.001; Figure 5.2). 
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Table 5.1. Patient characteristics between the different operators. 
 Characteristic Operator A Operator B Operator C p-value 
n 50 50 50  
Male, No./total (%) 24/50 (48) 20/50 (40) 30/50 (60) 0.0161 
Age, mean (SD), years 74 (9) 71 (11) 69 (10) 0.13 
Body Mass Index, mean (SD), kg.m-2 28 (4) 27 (4) 29 (4) 0.021 
 1 Statistical difference detected between operator B and C, no significant differences detected between operator A and each of the control 
groups.
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Table 5.2. The CA procedural characteristics for the different operators. 
Characteristic Operator A Operator B Operator C p-value 
Right Femoral Artery, No./total (%) 45/50 (90) 50/50 (100) 48/50 (96) 0.125 
Dose Area Product, median (IQR), Gy.cm2 634 (489-787) 972 (801-1498) 1502 (946-2079) <0.001 
Reference Air Kerma, mean (IQR), mGy 101 (75-128) 169 (134-245) 235 (149-321) <0.001 
Fluoroscopic Time, mean (IQR). minutes 2.2 (1.7-2.8) 1.9 (1.4-2.6) 2.6 (2.3-3.3) <0.001 
Acquisition Runs, mean (SD) 10 (2) 8 (2) 10 (2) <0.001 
LV%, No./total (%) 43/50 (86) 40/50 (80) 48/50 (96) 0.052 
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Figure 5.1. Comparison of DAP values between operators utilising the 3pps and 10pps setting. Error 
bars represent the interquartile ranges. Operator A is statistically significantly lower than Operator B 
and C. 
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Figure 5.2. Comparison of Reference Air Kerma values between operators utilising the 3pps and 
10pps setting. Error bars represent interquartile ranges. Operator A is statistically significantly lower 
than Operator B and C. 
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Figure 5.3. Comparison of Fluoroscopy Time between operators utilising the 3pps and 10pps setting. 
Error bars represent interquartile ranges. There is no significant difference between Operator A, and 
Operator B and C. Operator B is statistically significantly lower than Operator C. 
5.4 Discussion 
The results of this study demonstrated that compromise of imaging clarity during fluoroscopy 
by utilising ultra-low pulse rate does not adversely affect the performance of catheterisation 
by the operator while having a significant impact on radiation dose reduction. 
Several studies show that the typical radiation dose associated with CA procedures is 14-63 
Gy.cm2 (Hart and Wall, 2002, Vijayalakshmi et al., 2007, Einstein et al., 2007).  The median 
dose for the procedures using ultra-low pulse rate fluoroscopy in this study was 6.34 Gy.cm2. 
The reduction in radiation dose achieved is because fluoroscopic runs themselves can impact 
greatly on total procedural radiation dose delivered. The accumulated procedural radiation 
dose in the 3pps group was lower than that of the 10 pps control groups by as much as 58%. 
This reduction indicates that by manipulating only the fluoroscopic dose without adjusting 
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the cine acquisition protocols can in itself lead to notable dose optimisation. Further, our 
clinical data supports a previous phantom study that showed a significant radiation dose 
reduction when using ultra-low pulse rates in a simulated environment (Lederman et al., 
2002). This study also showed that the radiation dose in CA could be optimised to 
significantly lower ranges than stated in the existing literature.  
Other clinical studies have used pulse rate, and frame rate manipulation as a method of 
radiation dose reduction however only pulse rates as low as 7 pps have been reported 
(Schneider et al., 2015, Seiffert et al., 2015, Plourde and Bertrand, 2017, Hansen et al., 2016). 
This study showed that it is possible to reduce the pulse rate even further (as low as 3 pps), 
and consequently further reducing radiation dose, by working with the manufacturer of the 
fluoroscopic equipment to modify the standard noise reduction algorithms and frame 
averaging functions. The lower the pulse rate utilised, the higher noise, since fewer X-ray 
photons are forming the image, and therefore additional noise suppression is needed. This 
modification may not be possible on older systems due to the limitations of the system’s 
software. Thus, the authors recommend the protocol set up be done in consultation with the 
manufacturer when utilising ultra-low pulse rates in CA. The manufacturer can ensure any 
image ghosting, and perceived cadence is adjusted to allow sufficient image clarity. 
The results of the survey revealed that there was a short period required to adapt to the altered 
image quality. However, this was not a major limitation. In implementing this method of dose 
optimisation, consideration could be given to lowering the pulse rate from 10 pps to 3pps in 
incremental steps. For example, it may be preferable to reduce the pulse rate to an 
intermediary level such as 6 pps to assist in the transition to 3 pps. 
A concern of this study was that lowering the pulse rates could result in prolonged FT to 
compensate for the degraded image quality. The results showed that there was no increase in 
FT in the low pulse rate group as compared to the control groups.  
5.4.1 Limitations 
It is important to recognise that the operators who participated in this study are experienced 
cardiologists with many years of experience who have individual preferences when 
performing a CA. Thus, the average radiation dose imparted during a particular CA may 
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differ even if all other factors remain the same. Further blinded studies using the same 
operator, utilising both the 3pps and 10pps settings, may be beneficial to account for intra-
operator differences.  
5.5 Conclusion 
Findings from this pilot study suggest that utilisation of ultra-low pulse rate fluoroscopy in 
conventional transfemoral diagnostic coronary angiography in the catheterisation laboratory 
is feasible.  Adoption of this protocol may lead to significant reduction in radiation exposure 
to the patient and laboratory staff without significantly prolonging the procedure.  The 
application of this approach in interventional and trans-radial catheterisation procedures may 
be suitable for further investigation as it may potentially demonstrate more substantial 
radiation dose reduction. 
5.5.1 Ethics Approval 
This project was subject to Ethics approval by the Research Ethics Committee at the Austin 
Hospital (LNR/16/Austin/24) (Appendix A).  
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6 Patient Radiation Dose Optimization 
6.1 Introduction 
Interventional cardiology procedures have increasingly become vital to the current day 
practice of cardiology. However, as they heavily rely upon ionising radiation, close attention 
needs to be paid to the radiation dose imparted to decrease the risk of side effects. Radiation 
dose optimisation is, therefore, an important consideration in the practice of interventional 
cardiology. However, such optimisation techniques must also deliver adequate information to 
meet the clinical needs of cardiologists as well as not hinder the training needs of junior staff 
in teaching hospitals. 
Radiation-induced side effects have been well documented in the literature and are divided 
into two categories: deterministic and stochastic. Deterministic side effects include radiation 
burns and hair loss while stochastic side effects materialise over a longer time frame, as in the 
case of radiation-induced carcinogenesis. From a clinical vantage point, radiation side effects 
have ramifications for both the clinician and the patient: the former from prolonged 
occupational exposure to radiation, and the latter from the procedure itself. As such it is 
crucial to optimise radiation dose imparted to as low as reasonably achievable. 
A key factor in addressing dose optimisation is monitoring the large number of routine 
coronary angiograms that occur at tertiary teaching hospitals. The radiation dose imparted in 
teaching hospitals can surpass normal limits due to the longer procedural duration necessary 
to accommodate teaching needs of junior doctors. Consequently, radiation dose parameters 
must be optimised to ensure that, although fluoroscopic times may be unchanged, the 
radiation dose be reduced to an acceptable level. These changes should not impact on both 
the clinical outcomes and the training needs at teaching hospitals. Similarly, the dose 
imparted should be comparable to published and local dose levels to ensure safe radiation 
practice. 
Dose optimisation techniques explored in the literature target pulse rate and frame rate, as 
well as determining optimal positioning. Kuon et al. were able to achieve reductions in mean 
DAP from 53.9 to 12.9 Gy.cm2 for routine coronary angiography/angioplasty during a 
focused, year length study by reducing cinegraphic frames/runs, fluoroscopy time, finding 
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optimal positioning of blinds and filters and favouring low radiation views for visualisation 
of the left anterior descending (LAD) and diagonal arteries (Kuon et al., 2014). Similarly, A 
four step program implemented by Seiffert et al. showed a 54% reduction in DAP following a 
frame rate reduction, the use of fluoroscopy storage and strict use of beam collimation 
(Seiffert et al., 2015). McFadden et al. showed a dose reduction of up to 49% could be 
achieved in a paediatric phantom study by lowering the CINE frame rate from 30fps to 15fps 
with small reductions in image resolution (McFadden et al., 2013).  
The premise behind this chapter originated in the clinical need to reduce radiation dose 
imparted following a review of routine coronary angiograms. This review is conducted via a 
department audit which deemed the dose at this hospital greater than literature values. This 
chapter aims to build on the results of the previous chapter and clinically apply dose-saving 
techniques as well as educate the staff in radiation dose optimisation. Thus, this chapter will 
analyse the effects of varying optimisation protocols on routine coronary angiograms, from 
the perspective of a large metropolitan tertiary centre implementing dose optimisation 
techniques. A secondary aim is to determine which combination of radiation parameters 
contributes the most to a reduction in patient radiation dose.  
6.2 Methods 
6.2.1 Setting 
This study was conducted in a cardiac catheterisation laboratory of a large Victorian 
metropolitan teaching hospital. The staff consisted of experienced cardiologists and members 
of the Royal Australian College of Physicians (RACP) as well as fellows and registrars. The 
radiographers rotating through the time frame of the study were of varying seniority, from 
interns to radiography supervisors. The fluoroscopic X-ray unit used in this study was a 
Shimadzu Trinias F8 (flat panel detector technology) which had undergone all quality control 
tests subject to Australian Regulations in the state of Victoria. The onboard DAP meter was 
assessed for accuracy and was within 5% of an independently calibrated detector at the 
typical kVp range for cardiology procedures. 
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6.2.2 Study Design 
Before the commencement of this study, an audit was conducted on 30 routine coronary 
angiograms. This audit was done as part of hospital quality assurance and was independent of 
this study itself. The results of the audit showed that the median DAP was found to be 75 
Gy.cm2, a level which exceeded current literature, 14-63 Gy.cm2  (Hart and Wall, 2002). At 
the time of writing, there were no established local diagnostic reference levels for coronary 
angiograms in Australia. 
All patients undergoing diagnostic coronary angiography - with or without an additional left 
ventriculogram (LV) - between March and September 2016 were included in this study. 
Patients who also underwent a graft study, right heart study, aortogram, IVUS (intravascular 
ultrasounds) or any intervention on top of the routine cardiac diagnostic angiograms were 
excluded. 
There were five observational phases in this study, each phase lasting one month. Phase 1 
was a tailored radiation awareness talk which detailed the current radiation dose levels at the 
facility plus targeted advice on how to reduce this dose. Suggestions included collimation, 
adjustment of patient positioning and recommendation in reducing the fluoroscopic time. 
Phases 2-5 are a gradual decrease of the cine acquisition frame and dose rate and the 
fluoroscopic screening pulse and dose rate. Table 6.1 describes the frame rates, pulse rates 
and dose settings in each of the phases of the study. 
The data from each phase of this study are compared. The primary outcome measure was 
dose area product and reference air kerma. The secondary outcome measure was fluoroscopic 
time. 
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Table 6.1. Selected frame rate and pulse rate settings during the different phases of this study. 
Phase Frame Rate (FPS)/Dose Setting Pulse Rate(PPS)/Dose Setting 
1 15/normal 7.5/normal 
2 15/normal 7.5/low 
3 15/normal 5/low 
4 10/normal 5/low 
5 10/low 5/low 
6.2.3 Data Collection 
Radiation dose data, total study time, the number of acquisitions, patient age, sex, height and 
weight is collected through the procedural radiation dose structured report (RDSR). All 
radiation quantities are measured using the onboard DAP detector. Data collection was 
automated, discussed in further detail in chapter 3, and is collected following the completion 
of each patient case. The information regarding left ventriculogram and access site is 
gathered from the procedure files of cardiac technologists. Data relating to each phase of the 
study is collected during the duration of that phase.  
6.2.4 Statistical Analysis 
A one-way ANOVA is used to analyse for the effect of BMI and age on the measured 
outcomes, while for the non-normal variables of air kerma, DAP and fluoroscopy time, a 
Kruskal-Wallis H test is used. When a significant difference is detected in the non-normal 
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data, a pairwise comparison using a Mann-Whitney U Test with Bonferroni P-Value 
Adjustment is conducted. All categorical data were compared using a Chi-Squared test. 
Statistical analysis is performed on R V3.3.2. 
6.2.5 Image Quality 
Image quality is evaluated on patient images by experienced cardiology consultants through 
the duration of each phase. The assessment is undertaken during procedures and verbally 
communicated at multi-disciplinary meetings which included a consultant cardiologist, a 
physicist and a radiographer. Questions asked were: Is there a notable difference in image 
quality? Is the image quality sufficient to complete the procedure? Moreover, is there a need 
to increase the dose in certain angulations or views.  
6.3 Results 
A total of 491 patients is included in the study. A Kruskal-Wallis H test was conducted to 
detect a statistically significant difference between phase and each of DAP, air kerma and 
acquisition time.  A post hoc Mann-Whitney U test with Bonferroni p-value adjustment was 
used to detect the difference within phases. 
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Table 6.2. Patient characteristics of phase-specific populations. 
Characteristics Phase 1 Phase 2  Phase 3 Phase 4 Phase 5 p-value 
n 129 79 156 76 51  
Male, No./total (%) 81/129 (63) 52/79 (66) 98/156 (63) 43/76 (57) 34/51 (67) 0.839 
Age, mean (SD), years 64 (11) 64.1 (12.8) 65.2 (10.28) 65.9 (11.9) 63.4 (10.7) 0.61 
Body Mass Index, mean (SD), 
kg.m-2 
29.5 (5.65) 29.3 (6.2) 30.3 (6.6) 29.6 (6.2) 29.0 (4.5) 0.6 
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Table 6.3. The CA procedural characteristics of phase-specific populations. 
Characteristics Phase 1 Phase 2  Phase 3 Phase 4 Phase 5 P-value 
LV% 87 86 86 79 80 0.821 
Radial % 57 72 66 61 59 0.215 
No. acquisitions 8.4 (1.6) 8.3 (1.7) 8.4 (1.5) 8.6 (1.5) 8.5 (1.7) 0.8 
Air kerma (mGy) 0.68 (0.47-0.95) 0.63 (0.4-0.84) 0.59 (0.42-0.80) 0.46 (0.29-0.57) 0.3 (0.2-0.38) <0.0001 
DAP (Gy.cm2) 60.2 (43-84.6) 53.0 (36.5-69.7) 49.2 (36.5-68.4) 36.4 (25.2-46.9) 28.0 (17.6-35.2) <0.0001 
Total study time 4.5 (3.4-6.4) 4.8 (3.6-7.6) 5 (2.8-7.0) 5 (2.6-7.6) 4.2 (3.2-6.4) 0.189 
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A Kruskal-Wallis H test showed that there was a statistically significant difference in DAP 
values between the different phases, χ2(2) = 106.66, p <0.0001. There was also a statistically 
significant difference in air kerma between the various phases, χ2(2) = 89.606, p <0.0001. 
However, there was no statistically significant difference in fluoroscopy times between the 
different phases, χ2(2) = 6.14, p = 0.189.  
 
Figure 6.1. Median reference air kerma values during the different phases of the study. The error bars 
represent first and third quartile values. 
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Figure 6.2. Median Dose-Area Product values during the different phases of the study. The error bars 
represent first and third quartile values. 
 124 
 
Figure 6.3. Median total fluoroscopic time values during the different phases of the study. The error 
bars represent first and third quartile values. 
Furthermore, a Mann-Whitney U Test with Bonferroni P-Value Adjustment revealed a 
statistically significant difference in DAP and air kerma between specific phases (p<0.001, in 
all instances), as seen in Table 6.3. There was no statistically significant difference in 
fluoroscopy time between phases.  
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Table 6.4. The phase-specific significant difference in cases where a significant difference is found 
(p<0.001 in all instances where there was a statistically significant difference). 
Phase 1 2 3 4 5 
1 - NSD NSD SD SD 
2 NSD - NSD SD SD 
3 NSD NSD - SD SD 
4 SD SD SD - SD 
5 SD SD SD SD - 
Feedback regarding the image quality during every phase was that following the initial 
change; the first procedure would appear slightly grainy. The graininess was unnoticed 
following 1 or 2 procedures as the eye adjusted to the new settings. The image quality was 
sufficient to complete the examination, and there was no need to increase the dose except for 
steep angulations on obese patients.  
6.4 Discussion 
Due to the need to accommodate for the training of junior staff, teaching hospitals can be 
associated with longer procedure times which result in an increased radiation dose. Following 
the education talks in phase 1 of this study, the median procedure time was 4.5 (3.4-6.4) mins 
with a DAP of 60.2 (43-84.6) Gy.cm2. At the conclusion of the study, the fluoroscopy time is 
4.2 (3.2-6.4) min, and the DAP was 28 (17.6-35.2) Gy.cm2. 
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While a statistically significant dose reduction (DAP & Air Kerma) is not observed in every 
single phase, there is a downward trend in dose over the 5 phases. There is a statistically 
significant dose reduction observed when the frame rate is lowered from 15 to 10. The 
biggest change to impact on the reduction is a change in ‘Dose per Pulse’ rather than ‘Dose 
Rate’. For example, the most statistically significant reductions occurred when the dose 
setting is changed from normal to low dose on the fluoroscopic system. Comparing the DAP 
to the audit data found independently previous to this study there has been a 63% dose 
reduction in radiation dose.  
No statistically significant change in total fluoroscopy time is noted, implying that the 
reduced dose settings do not impact on the procedure and thus training of junior staff - 
specifically, that procedure length did not need to be increased to account for reduced image 
clarity.  
A short transition time is experienced in upskilling operators to use a lower image quality, 
however not only is this quickly surpassed, but the clinical outcomes of the procedure are 
also not impacted. The incremental reduction in dose settings in this study allowed the 
operators to adapt to the decreased image quality. Feedback from consultant cardiologists is 
that image quality was adequate during every phase. During routine procedures on average 
sized patients, no adjustments to dose rates were necessary throughout the duration of the 
examination. The only instance when an increase in dose rates was required is the 
combination of obese patients and steep angulations. 
The presence of Phase 1 - a targeted radiation awareness talk - is also deemed to be crucial to 
the success of the study, particularly given the varying seniority of the staff base, as well as 
their rotating schedule. Regular review of important concepts in dose optimisation could play 
a fundamental role in reducing radiation dose. This is highlighted by the decrease in dose 
levels from 75 Gy.cm2 (pre-study) to 60 Gy.cm2 (phase 1) where the only difference between 
the two phases is the educational talk given before the commencement of phase 1.  
We recommend that CA procedures be performed at 10 FPS/low for cine acquisitions and 5 
PPS/low for fluoroscopic screening, or equivalent low dose pulse options in different 
fluoroscopic/angiographic systems as a standard. Patient characteristics or procedural 
complexities may necessitate changes to settings as instituted by the radiographer or operator, 
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however routine radiation safety talks can provide assistance in how best to manage radiation 
dose settings to ensure that radiation dose to the patient remains as low as reasonably 
achievable. We believe using the incremental dose reduction methods employed in this study 
and in conjunction with the equipment manufacturer it may be possible to lower the frame 
and pulse rate even further to 7.5fps and 3.75pps. 
6.5 Conclusion 
A significant radiation dose reduction from lowering both frame rate and dose per pulse is 
seen in routine coronary cardiac angiograms. Furthermore, no adverse impact is made on 
diagnostic clarity, and no detrimental impact on the teaching of the junior staff is seen. The 
author suggests that a 10 fps/low and 5 pps/low setting should be used as a standard in CA 
procedures to achieve dose optimisation, with radiation settings being incrementally changed 
when necessary to account for patient complexities and characteristics. 
6.5.1 Ethics Approval 
This project was subject to Ethics approval by the Research Ethics Committee at the Austin 
Hospital (LNR/16/Austin/373) (Appendix B). 
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7 Quantification of Operator Dose 
7.1 Introduction 
Ionising radiation forms the backbone of cardiac angiography (CA) procedures. However, it 
is not without its own risks. Radiation scattered from the patient exposes the medical staff to 
potentially harmful effects. While there exists a number of tools to mitigate the operator’s 
radiation exposure (Badawy et al., 2016), some areas conventionally have remained 
unshielded. Furthermore, new evidence suggests low-dose protracted radiation over the 
operator’s working life may have harmful side effects. 
These effects are investigated in the field of radiation dosimetry, which correlates dose and 
radiation-induced disease. It is recommended that a single radiation detector is worn under 
the lead apron, however, if an unshielded body part on the operator is near the radiation 
source then a second dosimeter should be worn to estimate the dose to that region. In the 
author's experience, the cardiac catheterisation laboratory staff typically use a single radiation 
dosimeter to estimate whole body radiation dose and associated lifetime risk. However, as 
this device is shielded by the operator’s lead apron, the measured dose does not provide 
accurate information about body parts that are not shielded, for example, the lens of the eye, 
the brain or the extremities. Hence knowledge of typical absorbed dose at certain organs is 
necessary. Furthermore, organ-specific estimation factors are required to calculate the 
radiation dose to these organs, based on readily available radiation dose metrics such as 
patient dose measures.  
The literature suggests a variety of clinical manifestations for the radiation-induced disease. 
For example, the high risk of radiation-induced lens changes arising from external radiation 
exposure has been widely reported (Ciraj-Bjelac et al., 2010, Vano et al., 2010). More 
recently, evidence has surfaced on the risk of radiation-induced brain malignancies (Roguin 
et al., 2013). The unshielded head of the operator and their comparatively over-exposed left 
side has been seen to correlate with left sided brain tumours.  However, despite the existence 
of a broad range of literature on the topic of radiation-induced disease, there are some gaps. 
For example, conflicting evidence exists as to the incidence of breast cancer in medical 
workers exposed to radiation, with reports of increased breast cancer in radiation 
technologists prior to the 1970’s but not after, which is a testament to the evolution of 
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radiation protection tools (Doody et al., 1998, Doody et al., 2006, Wang et al., 2002). 
However, the interventional cardiologist, due to their proximity to the patient, is exposed to 
more radiation than the technologist, and thus it is worthwhile to evaluate the radiation 
exposure to the operator’s breast, as well as other radiosensitive regions such as the groin, 
during CAs. 
Hence this study aims to do the following: 
1. Quantify the typical absorbed dose at a number of regions of the operator’s body in 
routine CA 
2. Provide factors to estimate the radiation dose to these different regions based on readily 
available patient dose metrics, such as Dose-Area Product (DAP) 
3. Provide an evidence-based guideline as to the necessity of extra radiation protection for 
operators.  
7.2 Method 
7.2.1 Equipment 
This study used an anthropomorphic full body ATOM dosimetry verification phantom 
(CIRS, Virginia, USA) to simulate the scattered radiation from the patient. This phantom 
emulated a 73 kg, 173 cm tall adult male. It was selected since the electron density of the 
tissue equivalent materials closely resembled that of a real patient (Computerized Imaging 
Reference Systems, 2013). 
The simulated procedure was conducted on a Shimadzu Safire flat panel X-ray Imaging 
System (Shimadzu Corporation, Kyoto, Japan) which had undergone all quality control tests 
subject to Australian Regulations in the state of Victoria (Department of Health and Human 
Services, 2007). The patient dose was collected using the DAP meter installed on the 
fluoroscopic equipment. The DAP meter was tested to be within 10% over the kVp utilised in 
the simulated procedure. 
The simulated operator was protected using a ceiling mounted lead shield, a lead apron, and 
table lead skirts. A mannequin was used to replicate the cardiologist's position during a CA 
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To measure the entrance exposure on the operator’s body due to the scattered radiation. TLD 
100 rods was placed on different anatomical regions (Figures 7.1 & 7.2). 
7.2.2 Simulated Procedure 
A routine CA was performed by an experienced cardiologist at a large metropolitan tertiary 
hospital. The frame rate for the CINE acquisitions was 15 fps, and the fluoroscopic rate was 
7.5 pps. The angulations used are listed in Table 7.1. The average acquisition length was 6 
seconds. 
7.2.3 TLD measurement, annealing and reading 
The thermoluminescent dosimeter (TLD) Harshaw TLD-100 rods were selected in this study 
due to their ability to measure exposures as low as 10 µGy, which is appropriate for low 
energy scatter radiation. The lack of sensitivity to light of the material is also advantageous as 
these chips are to be placed on the phantom unprotected from light. Further, the Lithium 
Fluoride material is near tissue-equivalent allowing for good estimation of absorbed dose to 
tissue without the need for the application of material absorption correction factors. The 
TLD-100 rods were individually calibrated for their dose response using a 55 kVp beam with 
1 mm of Al filtration. The choice of 55 kVp was used to simulate the energy range of the 
scattered photons as we do not measure the direct beam. Each TLD is exposed to 138 mGy 
which was equivalent to 1 Monitor Unit on the superficial radiotherapy unit used. The typical 
dose measured is expected to be in µGy nevertheless an advantage of TLD-100 rods is that 
they have a linear response at low doses. However, the TLD readings may exhibit high 
standard deviations at doses below 300 µGy (Bauk et al. 2011). 
10 TLD rods were used and averaged to measure background for dose corrections. 60 TLD 
rods were placed in plastic pouches and attached at different locations on the mannequin 
(Figure 7.2). Each site had three TLDs and the dose measured was averaged to account for 
measurement errors and variations between the TLD rods.  
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Table 7.1. Angulation used to for the CINE acquisitions in the simulated coronary angiogram.  
Artery Imaged RAO LAO CRA CAU 
LCA 30   20 
LCA  30  30 
LCA 5  40  
LCA  30 25  
LCA 30  30  
RCA  30 20  
RCA 30    
* RAO denotes the right anterior oblique angle, LAO the left anterior oblique angle, CRA the 
cranial angle, and CAU the caudal angle for the fluoroscopic unit gantry. LCA is the left 
coronary artery, and RCA is the right coronary artery. 
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7.2.4 Backscatter Correction 
The decision to use the mannequin to simulate the operator rather than a human equivalent 
phantom was to allow for measurement of exposure to operator extremities as well as provide 
more range of movement to simulate the operator better. However, the mannequin is hollow 
inside, and therefore the backscatter would be considerably different to an operator. A 
backscatter correction factor is obtained by comparing the surface dose from a CTU-41 CT 
Torso (Kyoto Kagaku Co. Ltd, Kyoto, Japan) and the mannequin at one meter away from the 
patient using a RaySafe X2 Survey Sensor (Unfors RaySafe AB, Billdal, Sweden). This 
measurement is repeated five times, and the ratio between the CTU phantom and the 
mannequin is obtained. All subsequent TLD measurements on the mannequin were 
multiplied by this factor to account for backscatter. 
7.2.5 Effective dose calculation 
The highest dose, as measured with the TLD, in each compartment was used to determine the 
contribution from that compartment to the whole body effective dose. Weighting factors for 
each compartment are obtained from Table 6.3 in the Hanford method manual(Hill and 
Rathbone, 2010). The calculated weighted compartment dose was summed to estimate the 
whole body effective dose (Hp(10)g) using equation 7.1. The compartments used were Head 
and Neck, Thorax, Abdomen, Upper Right Arm, Upper Left Arm, Right Thigh, Left Thigh. 
Equation 7.1. Calculating the effective dose to the operator based on compartment factors. 
! = 	 $%&'×	)*  
Where Dmax is the maximum dose in each compartment and CF is the compartment weighting 
factor from Hill and Rathbone. 
Effective dose conversion factors from DAP were calculated using Equation 7.2 and have 
units (µSv/Gy.cm2). 
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Equation 7.2. Calculating conversion factors from patient dose to operator dose in µSv. 
)+,-./01+,	*234+/ = 	$56/! 
Table 7.2. Compartment factors used for equation 7.1 to calculate the whole body effective 
dose of the operators. Table reproduced from the Hanford Method Manual. 
Compartment Compartment Factor  
Head and Neck 0.108 
Thorax, above the diaphragm 0.307 
Abdomen, including pelvis 0.561 
Upper Right Arm 0.006 
Upper Left Arm 0.006 
Right Thigh 0.006 
Left Thigh 0.006 
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Figure 7.1. The experimental setup is emulating typical positioning of the operator during a routine 
coronary angiography procedure. 
7.3 Results 
The results are tabulated in Table 7.2 and presented graphically in Figure 7.2. The simulated 
CA procedure had a total fluoroscopy time of 1.98 mins, DAP of 31.2 Gy.cm2 and reference 
air kerma of 0.34 Gy. The table also displays the conversion factors necessary to estimate the 
dose received by target organs on the operator, calculated based on the readily available 
patient dose metric, DAP. The conversion factors provide an immediate qualitative 
illustration of the relative magnitude of received operator dose. 
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Table 7.3. Radiation exposure measured for various body parts during a routine coronary angiogram and compared to the literature. A conversion factor is 
presented derived from the total Dose-Area Product of the procedure. Review of published data before 2008 
TLD Location This Study 
(µSv) 
Vano (Vano et al., 
1998) (µSv) 
Kim (Kim et al., 
2008) (µSv) 
ORAMED (Donadille 
et al., 2011) (µSv) 
Conversion Factor 
(µGy/Gy.cm2) 
Right Brain 29.51    0.95 
Left Brain 149.93    4.81 
Left Eye 140.76 294 5-1120 52 (4-820) 4.51 
Right Eye 24.41 167 5-1120 52 (4-820) 0.78 
Thyroid 36.04 269   1.16 
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Left Armpit 44.80    1.44 
Right Armpit 23.88    0.77 
Left Chest 38.80    1.24 
Right Chest 16.91    0.54 
Left Hip 36.57    1.17 
Right Hip 9.46    0.30 
Left Groin 41.23    1.32 
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Right Groin 5.42    0.17 
Left Knee 21.12   163 (16-1567) 0.68 
Right Knee 4.65   62 (4-1232) 0.15 
Left Ankle 22.16    0.71 
Right Ankle 7.87    0.25 
Right Elbow 23.39    0.75 
Left Elbow 46.11 646   1.48 
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Right Hand 101.79 191 5-787 163 (8-1775) 3.28 
Left Hand 102.28 364 5-787 70 (8-579) 3.26 
Whole Body 53  0.2-38  1.71 
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Figure 7.2. The radiation dose received to the monitored regions on the operator’s body. The numbers 
on the phantom indicate the entrance dose in µSv. 
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The results show that the left side of the operator receives a greater amount of radiation 
exposure than the right and that there is a significant amount of radiation exposure to the 
brain and the eye. Furthermore, the results show that there may be a significant amount of 
radiation exposure to the left chest and left armpit. The exposure to the hands was also 
significant. 
The effective dose was calculated based on the compartments of the body that were exposed. 
It is found that the total external effective dose to the whole body was 53 µSv. This value 
results in a conversion factor of 1.71 µSv/Gy.cm2. At this institution, the whole body 
effective dose is estimated by one dosimeter worn under the apron at chest level. The highest 
dose received to the chest in this study was 39 µSv. This value is a 26% underestimation of 
the whole body effective dose. 
7.4 Discussion 
The results show that the left side of the operator received a greater amount of radiation 
exposure than the right, consistent with published data. This difference is due to normal 
operator positioning conventions in the room, which places the operator’s left-hand side first 
in the path of scattered radiation from the patient. 
The lens of the eye in the simulated CA procedure using only a leaded glass shield received 
up to 140 µSv. Using this exposure value for a typical CA procedure conducted at this 
establishment, the operator would surpass the annual dose limit for the lens of the eye (20 
mSv) by conducting 12 procedures a month. One would expect that exposure would be much 
higher if case numbers and complexity were greater, such as with coronary interventional 
procedures and consequently the annual dose limit would be surpassed earlier. Therefore, 
strong consideration should be given to wearing leaded glasses.  
The left brain receives a significant amount of dose if left unprotected. The results of our 
study confirm the findings in the literature, showing that the dose as measured on the 
mannequin is five times greater to the left brain than the right (Chumak et al., 2016, Reeves 
et al., 2015).  Given reports in the literature of left sided brain tumours these results show that 
extra protection may be necessary for complex procedures that lead to high radiation 
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exposure. Larger ceiling mounted shields, or disposable radio-protective skull caps can 
provide this protection. 
The radiation dose to the left armpit and left chest during a procedure may also be of concern, 
especially for female staff. One contributing factor to the high dose in this study is the fact 
that the unprotected gap under the arms is exaggerated because the apron does not fit the 
mannequin perfectly. This may be reflective of real world practice where custom made lead 
aprons are not always available for use. These results serve to confirm the advantages of 
having custom fitted lead aprons. 
A significant dose increase, eight times greater, on the left side is seen in the radiosensitive 
area of the pelvis (hip and groin). Further studies are required to provide correlations between 
lateralizing dose increase and radiation-induced disease to specific regions of the body. 
Moreover, this significant dose increase was measured in the setting of the operator already 
wearing conventional radiation safety equipment and suggests there may be a need for further 
optimise radiation protection strategies. 
Although the lower trunk if unprotected will receive the most radiation, it is evident that the 
use of the table lead skirt provided significant shielding to the operator. However, no 
radiation protection is typically used to shield the hands. Correspondingly, the exposure to 
the hands in our study was found to be high. Procedural modifications or the use of radiation 
attenuating gloves are suitable alternatives to mitigate this risk. However, the proportionate 
lack of radiosensitive tissue in the extremities make radiation protection to these areas lower 
priority.  
Whole body effective dose found in this study is greater than the typical effective dose found 
in the literature for diagnostic CA, which ranges between 0.2 - 38 µSv (Kim et al., 2008). 
From our results, one can see that the difference in dose between the left chest and the right 
chest is 39 and 17 µSv respectively. The variability between studies could be a result of 
dosimeter positioning. Furthermore, under apron dosimeters do not effectively account for 
unshielded areas in the body, which also contribute to the whole-body dose. 
The results vary significantly when also accounting for radiation to other body parts when 
calculating the whole body effective dose, in this instance 17-39 µSv at chest level as 
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compared to 53 µSv. This is a 26-68% underestimation of whole body effective dose. 
Therefore, this study agrees with recommendations that suggest that more than one dosimeter 
should be used to monitor the radiation dose to the operator effectively. It is suggested that 
the second dosimeter is worn on the operator's left collar, as this position correlates best with 
the dose to the eyes (Farah et al., 2013). However, the results of this study suggest that if only 
one dosimeter is to be worn the most appropriate location to estimate total body effective 
dose would be the left chest or left hip under the apron. 
Our research shows that the significant increase in radiation exposure to the left side of the 
body, and particularly the left eye, brain, armpit and chest, needs to be acknowledged when 
undertaking interventional procedures. There is the potential for adverse health events with 
this increase in radiation exposure which could be easily mitigated through both greater 
awareness and the selection of appropriate radiation protection equipment.  
This study builds upon established literature by providing an up to date review of operator 
dose, as well as including the operator dose to target organs that are not commonly reported. 
While our study uses a phantom model to estimate operator dose, this template can also be 
used as the basis for a clinical study in operators working in the cardiac catheterisation 
laboratory.  
7.4.1 Limitations 
This study was performed using a “standard” CA procedure for one operator and in one 
setting. Although the acquisition protocols are broadly similar, reproducing the study in 
different institutions among a range of operators would be of value. 
The study would benefit from measuring the dose on operators during clinical procedures. 
The mannequin proves limited freedom of movement between each exposure event which 
may not be reflective of the clinical situation. 
7.5 Conclusion 
Using a phantom model to estimate operator dose in a CA, an up to date review of radiation 
exposure to varying regions of the operator's body has been presented. This has facilitated the 
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calculation of conversion factors to estimate the operator dose from easily available patient 
dose metrics (DAP) over a comprehensive list of target regions. Our results confirmed 
current literature in detecting an increase in radiation exposure to the operator’s left-hand 
side.  
Our study also supports published data on the dose to the lens of the eye, and the brain while 
adding to the literature in describing dose quantification to the chest and groin. We 
recommend that operators optimise radiation protection to the head, which may be 
particularly relevant in complex and prolonged cardiac procedures. Finally, the use of one 
dosimeter under the lead apron underestimated whole body effective dose received by the 
operator by up to 68%, which can be mitigated by the utilisation of a second detector. 
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8 Real-time Operator Feedback 
8.1 Introduction 
Personal radiation dosimeters have been utilised for some years to assist in the protection of 
individuals exposed to ionising radiation. These dosimeters play a vital role in radiation dose 
management of staff in the clinical setting, particularly for interventional cardiology 
procedures. Historically dosimeters in this setting make use of TLD technology, requiring the 
operator to wear the dosimeter badge for a set period before being analysed and results were 
given back to the staff. While this can provide valuable information as to the accumulated 
occupational dose, it limits the ability to make changes to the procedure or to identify poor 
radiation practice in real time. Furthermore, it means that any procedural modifications the 
operator makes in the future are essentially blind corrections, without the advantage of 
directly being able to see the impact on radiation dose.  
Recently, real-time solid state dosimeters such as the RaySafe™ i2 have been introduced to 
combat this issue (Khosravinia, 2013, Inaba et al., 2014). These provide the advantage of 
showing the radiation dose in real time so that operators are aware of what they are receiving 
during the procedure. Such feedback takes the form of either numerical representation of 
dose imparted (thus providing a visual feedback) or signals which provide auditory feedback. 
There have been limited studies showing if this has led to dose optimisation in the cardiology 
setting. One study revealed that in conjunction with software monitoring patient radiation 
dose, reduction in operator dose is achieved  (Heilmaier et al., 2015) however this cannot be 
solely attributed to the real-time staff dosimeter based on the evidence provided.  A 
disadvantage of this system is that constant checking of dose can become visually distracting, 
or even ignored once its novelty has expired. Furthermore, systems that employ an audible 
signal for radiation dose monitoring may interfere with the sound made by the fluoroscopic 
equipment, a potentially marring distraction for an operator visually occupied in traversing 
patient anatomy.  Thus it is clear that solely relying on one mode of feedback can have 
negative implications.  
The objective of this chapter is to create a real-time radiation dose feedback system from 
existing technologies, which incorporates tactile as well as visual and audible feedback. This 
device can then be implemented in training scenarios to provide a multisensorial feedback 
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system which can positively influence learning behaviours in a simulated or clinical 
environment.  
8.2 Methods 
8.2.1 Hardware 
A commercially available Geiger Counter detector kit was used to create the detector module 
of the project. This kit came with an SBM-20 detection gas filled (Ne+Br2+Ar) chamber. 
Two AA batteries powered the module. The serial connections between the Geiger kit and the 
USB to the serial interface are listed in Table 8.1. To process the output data from the 
detector module a Raspberry Pi computer was used. Raspberry Pi is the name given to a 
series of small computers designed to promote computer science. Initially conceived in the 
UK, Raspberry Pi has garnered success worldwide due to its small frame, cost-effective 
computers that still maintain full functionality.  
The vibration module was connected via standard GPIO pin 4 to allow the Python code to 
interface directly with it using standard Raspberry Pi Python GPIO modules. The vibration 
has two modes HIGH and LOW representing ON and OFF state. This allowed for real-time 
manipulation of the vibration module to vibrate only when a threshold was met. 
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Table 8.1. Parts used to build the real-time detector system. 
Part Description 
Mighty Ohm 
kit 
Geiger counter device with a serial interface to read raw count input. 
Connects to USB serial interface (Keyzer, 2011). 
Raspberry Pi 2 
Model B 
Microcomputer used to host interfacing programs (Raspberry Pi, 2015a). 
USB to serial 
dongle 
Used to capture serial output to Raspberry Pi device. Connects from 
Mighty Ohm serial output to USB hub (Adafruit Industries, 2015). 
Vibration 
module 
Vibration module used for over count thresholds. Connects directly to 
Raspberry Pi GPIO (General Purpose Input/Output) pins (Adafruit 
Industries, 2016c). 
USB Wifi 
adapter 
WiFi adapter to set up Raspberry Pi as an access point for users to connect 
directly. Connects to USB hub (Raspberry Pi, 2015b). 
USB hub For port Raspberry Pi USB port expansion to handle all USB devices 
(Adafruit Industries, 2016b) 
5V Battery 
Pack 
Allows the Raspberry Pi and other devices to work on mobile power for a 
short period. Connects to USB hub power input (Adafruit Industries, 
2016a). 
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AA Batteries Used as a power source for Geiger counter tube. 
8GB MicroSD 
card 
Stores the Raspberry Pi Raspbian operating system. Inserts directly into 
Raspberry Pi 
 
 
Table 8.2. The connections between the Raspberry Pi and Mighty Ohm Geiger Kit. 
Geiger Kit Raspberry Pi Purpose 
Serial Pin 1 Pin 6 Ground 
Serial Pin 4 Pin 8 Transmit Data 
Serial Pin 5 Pin 10 Receive Data 
Pulse Pin 1  Pin 14  Ground 
Pulse Pin 3  Pin 1 3.3 V 
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Figure 8.1. Mightyohm Gieger Kit used in the detection module of the real-time operator feedback 
system (Keyzer, 2011). 
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Figure 8.2. A simple diagram of components in the real-time radiation detection system. 
8.2.2 Software 
The Raspberry Pi was configured using the standard Raspbian operating system with 
download and instructions from Raspberry Pi webpage (Raspberry Pi, 2016) and installed on 
the 8GB Micro SD card. The process is simple and only requires an existing Windows, Mac 
or Linux computer, a MicroSD card reader, and a piece of software to write the base image 
onto the SD card. 
After initial boot, the Raspberry Pi was configured as a WiFi access point so that users could 
connect to the web interface directly to review the log output. Instructions from an Adafruit 
learning resource is used (Ada, 2013). This is done as no existing WiFi infrastructure 
connects to the Raspberry Pi device. 
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A Python script called feeder.py was configured to launch from rc.local at boot time. This 
script takes in USB to serial device file /dev/ttyUSB0 as an argument, reading in values from 
the serial to USB detector and writing them in real-time to log file at /var/www/log. If the 
total dose were greater than the threshold number set it would activate the buzzer via the 
GPIO ports. When the user launches the device's web interface a bit of javascript is run that 
watches the log file and displays it on the user's screen. 
 
#!/usr/bin/python3 
#  
# feeder.py 
# 
# Takes counts from USB geiger counter and inserts into log file.  
# Activates buzzer on seperate GPIO port if condition is met. 
#  
# Author: Mohamed Badawy 
# Date: 01/06/2016 
# 
import sys 
import os 
from datetime import datetime 
import time 
import serial 
import RPi.GPIO as GPIO 
 
# conversion factor CPS to uSv 
cps_usv=1.8 
#convert seconds to hour 
s_h=0.000277778 
in_fname = sys.argv[1] 
connected=0 
# Loop until serial device available 
while connected != 1: 
   try: 
          inf=open(in_fname, 'rU') 
          connected=1 
   except: 
          time.sleep(5) 
          pass 
total_counts=0 
#start time 
start_time = datetime.now() 
buzPin=4 
GPIO.setmode(GPIO.BCM) 
GPIO.setup(buzPin, GPIO.OUT) 
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# Read total_counts from device 
while True: 
   try: 
          line = inf.readline() 
          if line == '': break 
          if line == '\n': continue 
          cps = line.split(',')[1].strip() 
          if cps.isdigit() == False : continue 
          cps = int(cps)  
          if cps > 0: 
                  GPIO.output(buzPin,GPIO.HIGH) 
          else: 
                  GPIO.output(buzPin,GPIO.LOW) 
           
          dose_rate=cps/cps_usv 
          total_counts+=cps 
          total_time=int((datetime.now()-
start_time).total_seconds()) 
          total_dose=total_counts*total_time*s_h 
            # activating buzzer (if dose is greater than 30) 
          if int(total_dose) > 30: 
            GPIO.output(buzPin,GPIO.HIGH) 
          else: 
            GPIO.output(buzPin,GPIO.LOW) 
          with open("/var/www/log", "a") as fo: 
                  fo.write(str(total_time) + "\t" + str(cps) + 
"\t" + str(round(dose_rate,2)) + "\t" + str(round(total_dose,2)) + 
"\n") 
   except Exception as e: 
          print(e) 
          pass 
 
 
Apache and PHP services were then installed onto the operating system to handle the web 
interface code. This code references javascript code from written by the UK High Altitude 
Society (UK High Altitude Society, 2015) which allows watching of a flat file for changes. 
This flat file at location /var/www/log is where the Python feeder.py script writes count 
information from the Geiger Counter to the filesystem. The <pre id=”data”> tag in the 
HTML code is where the javascript code inserts the most recent output. The code allows 
reversed and chronological log ordering.  
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<html> 
   <head> 
       <title>habitat parser log viewer</title> 
       <script type="text/javascript" src="jquery.min.js"></script> 
       <script type="text/javascript" src="logtail.js"></script> 
       <link href="logtail.css" rel="stylesheet" type="text/css"> 
   </head> 
   <body> 
       <div id="header"> 
    <a href="/">Home</a> -  
           <a href="/live.php">Reversed</a> - 
           <a href="/live.php?noreverse">Chronological</a> 
       </div> 
 <h1> 
 SEC&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CPS 
       <pre id="data">Loading...</pre> 
 </h2> 
   </body> 
</html> 
 
The data was logged by connecting the Raspberry Pi output with a serial port (J7) to a serial 
to USB adapter and capturing the feed using the raw serial output. The data was reported by 
the unit in CSV format as follows: 
CPS,#####,CPM,#####,uSv/hr,###.##,Slow|Fast|INST 
 
Where CPS is the counts per seconds, CPM is the counts per minutes, uSv/hr is the 
equivalent dose rate, and the last value indicating the mode of operation. This is selected 
automatically based on if the last five measured counts exceed the threshold.  
This output is manipulated by the feeder.py script to populate the log file which the web 
interface uses to present counts to the user. 
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8.2.3 Calibration 
A Caesium 137 (137Cs) isotope was used as a calibration source. Two activities, 3.7 GBq and 
145 GBq, of this source, were placed in front of a railing that the detector can be placed upon. 
The detector was then moved at set distances away from the sources to measure different 
count rates. At each location, a measurement was taken over a total of 10 seconds. This is 
then repeated five times, and the count rate is averaged. Linearity testing of the detector 
assessed the ability of measuring different dose rates accurately.   
 
Figure 8.3. The detector on the calibration rails in the calibration laboratory. The detector was moved 
to set locations which corresponded to known count rates. 
8.3 Results 
A functional prototype of the detector was built and tested in the hospital environment during 
simulated cases. The detector is worn on the outside of the lead apron to measure the 
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radiation scattered from the patient towards the staff members. Figure 8.4 shows an image of 
the prototype. 
 
Figure 8.4. The real-time detector prototype showing the detection module (left), side view (centre) 
and computational and battery modules (right). 
The measured exposure is transmitted to the Raspberry Pi which is accessed from anywhere 
in the vicinity using Wi-Fi and a display monitor. In this experiment, a tablet PC is used for 
portability, and the display is mounted near the displays for the fluoroscopic images. Results 
could either be presented as counts per seconds in real time (Figure 8.5) or graphically 
(Figure 8.6). The tactile feedback is set to vibrate on the operators back based on exposure 
rate, i.e. the vibrations get more intense as the operator is subjected to more radiation such as 
getting closer to the patient or increase the dose rate settings on the fluoroscopy unit. The 
position of the vibration module can be changed to anywhere on the operator’s body and the 
vibration intensity and threshold are able to be changed through the source code. 
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Figure 8.5. A log of the output from the real-time detection device. The first column represents the 
time, the second represents the counts per second, the third represents the dose rate in (uSv/hr), and 
the fourth column represents the accumulated dose (uSv) over the averaged period. 
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Figure 8.6. Detected counts from external radiation source presented graphically as a function of time. 
8.3.1 Calibration 
The background in the calibration laboratory was measured using a Health Physics 
Instruments Model 1010 (SN:419) and was 0.5 cps which is equivalent to 0.08 uGy/h. 
Linearity data and estimated uncertainty in the instrumentation is presented in Table 8.3. Raw 
data presented in Appendix C. The results of calibration against radiation sources with a 
known dose rate showed that the detector is appropriate for accurate measurement (within 
20%) of air kerma rates greater than 13 µGy/h. The uncertainty is derived from the standard 
deviation of the measurements. The cps to dose rate was derived using the response of the   
Geiger counter to a known dose rate in the calibration laboratory. 
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Table 8.3. The linearity of the detector response to different count rates using a 137Cs (662keV) radiation source at set distances from the detector. All the 
data has been background corrected. 
Radiation Source Measured Count 
rate 
Actual air kerma 
rate (uGy/h) 
Instrument linearity Estimated uncertainty 
(+-%) 
137Cs (3.7 GBq) 0.4 0.33 1.2 294 
137Cs (3.7 GBq) 2.00 0.66 3.04 95 
137Cs (3.7 GBq) 3.00 1.28 2.33 64 
137Cs (145 GBq) 7.40 3.18 2.33 24 
137Cs (145 GBq) 16.2 6.94 2.33 23 
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137Cs (145 GBq) 22.2 9.42 2.36 21 
137Cs (145 GBq) 27.8 13.8 2.02 18 
137Cs (145 GBq) 61.8 27.4 2.26 13 
137Cs (145 GBq) 127 59.8 2.12 10 
137Cs (145 GBq) 179 81.2 2.21 11 
137Cs (145 GBq) 254 118 2.15 11 
137Cs (145 GBq) 368 174 2.11 8 
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137Cs (145 GBq) 786 380 2.07 8 
137Cs (145 GBq) 988 516 2.92 8 
137Cs (145 GBq) 1419 753 1.88 6 
137Cs (145 GBq) 1667 929 1.80 8 
137Cs (145 GBq) 3162 2030 1.56 7 
137Cs (145 GBq) 3919 2756 1.42 7 
137Cs (145 GBq) 5016 4022 1.25 5 
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8.4 Discussion 
The prototype was used in a simulated environment and showed appropriate sensitivity to 
measure the scattered radiation even from long distances away from the patient equivalent 
phantom. The aim of this detector was not to accurately quantify the radiation dose (although 
the calibration results show that it is possible with appropriate correction factors) but to 
relatively get a measure of the exposure in different scenarios. For example, it is important to 
get feedback from the audible sounds or vibration modules that decrease in intensity as the 
operator increases their distance from the source. This feature can facilitate the teaching of 
hands-on safety training. 
A training program should be set up with patient equivalent phantoms in the catheterisation 
laboratory where the operator would be routinely working. The operator should be directed to 
simulate a procedure on the phantom while instructed of radiation dose optimisation methods 
which are both staff specific and patient specific. The feedback provided by the detector 
system can reinforce how specific ways can reduce the radiation exposure that the operator is 
receiving. Methods such as using different parameters, reducing frame rates, increasing field 
size, collimating, angulations, varying the patient geometry, increasing distances, shielding 
and angulations should all be considered as means of reducing radiation dose.  
The choice of wearing the detector on the outside of the lead apron is due to it being 
advantageous to quantify the radiation dose incident on the operator from the scattered 
photons originating from the patient before any shielding. This location enables the detector 
to have a higher sensitivity and facilitate more feedback to the operator. Further, radiation 
reduction strategies will be more pronounced if the radiation incident on the operator pre-
shielding is measured, i.e. any minor change in protection methods will result in a larger dose 
reduction which is an excellent teaching tool. 
Before this detector can be used in the clinical setting several things must be addressed: 
1. Cables must be engineered to be safe in the clinical setting. 
2. The unit must be tested to ensure that the patient and operator will be safe from 
electrical shocks. 
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3. More than one detection system must be built to ensure there is a backup device 
during any clinical research. 
4. The system must be tested to make sure that there will be no interference with 
medical equipment of high voltage generators. 
Addressing the above issues would allow this system to serve as a useful tool in the research 
setting to provide real-time feedback on dose reduction methods rather than relying on time-
consuming TLDs (as used in chapter 7) or costly alternatives such as the RaySafe™ system. 
8.5 Conclusion 
Measurement of radiation dose to operators have traditionally utilised TLD technology. 
While TLD badges are convenient to wear, they can only provide a retrospective analysis of 
the dose delivered and thus cannot allow for real-time procedural modifications. Furthermore, 
solid state dosimeters that have been introduced to address this issue have distinct 
disadvantages: the need to check visual displays becomes visually distracting for the 
operator, and sounds emitted by some systems may interfere with those made by the 
fluoroscopic equipment.  This chapter presented the concept of a real-time dose detector that 
provided visual, auditory and tactile feedback to the operator, for the initial purpose of 
simulation and training in the area of radiation awareness. The hardware and software 
blueprints for the detector are presented. Results showed that the detector was appropriately 
sensitive to measure scattered radiation even from long distances and that the detector itself 
was practical to wear.  
. 
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9 Conclusion 
The objective of this thesis was the practical exploration of radiation dose optimisation in the 
cardiac catheterisation laboratory. The relevance of this thesis is grounded in the ongoing 
popularity of interventional cardiology procedures, which involve fluoroscopically guided 
interventions. Hence, given established evidence in the literature of radiation side effects, it is 
important to keep the dose imparted during procedures as low as possible.  
Consideration was first given to achieving a cost effective, automated method of data 
collection for the monitoring of radiation dose. A system created through the use of open 
source programming languages and data management software could intake information 
directly from fluoroscopic systems in the form of the radiation dose structured reports. The 
result is an automatic collation of the vast amount of information that is created and stored 
during a procedure. This system could further be used to calculate the patient skin dose and 
thus estimate the likelihood of tissue reactions in high dose procedures. The information 
collated could also be further analysed to achieve further radiation dose optimisation through 
audits, setting facility reference levels and education. 
The accuracy of the radiation dose metrics is a major limitation to the automatically 
calculated dose above. We assessed the accuracy of the dose metrics reported by different 
fluoroscopic units of different age and manufacturers. This experiment is necessary because 
not all metrics impacting on patient dose are required in regular quality control tests under 
Australian Regulations. The comparison of the standard DICOM values, as presented by the 
fluoroscopic units, with values that are directly measured allowed for the assessment of the 
accuracy of the information. Results showed that table height and FOV were the values that 
should be directly measured and accounted for when calculating patient skin dose. 
Furthermore, recommendations and guidelines are presented as to the frequency and 
tolerance of routine quality assurance. 
After establishing the accuracy of the displayed dose and creating a method for automating 
dose monitoring, the field of radiation dose optimisation is explored. Altering the 
fluoroscopic pulse rate has been a frequent target of dose optimisation during routine 
diagnostic coronary angiograms in the literature, with lowering the pulse rate being the 
common strategy. The third experiment in this thesis explored the use of a novel ‘ultralow’ 
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fluoroscopic pulse rate – at three pulses per second compared to the standard 10 – on routine 
diagnostic coronary angiograms performed at a large metropolitan centre. Results showed 
that a statistically significant reduction in DAP with no reduction in diagnostic clarity or 
increase in procedure length is feasible. Hence the author posits that further exploration in the 
field of ultra-low pulse rates could be a possible and practical target of dose optimisation in 
future studies.  
The actual implementation of radiation dose optimisation techniques in a relevant clinical 
setting – i.e. a large teaching hospital – was explored. The pertinence of this study is 
grounded in the fact that teaching hospitals routinely accommodate the teaching needs of 
junior staff, thus accounting for longer procedure times and consequently higher dose. The 
effect of a rapidly implemented dose reduction program, achieved by implementing different 
optimisation protocols in routine coronary angiograms, was studied. Results showed up to 
54% dose reduction – without negative outcomes on the teaching of junior staff – from 
lowering both frame rate and the dose per pulse. Maximal dose optimisation is achieved 
using a 10FPS/low for cine acquisitions and 5PPS/low for fluoroscopic screening however it 
is noted that patient complexities and characteristics would necessitate modification of 
settings.  
Radiation dose imparted to the operator was then considered, given the abundance of 
research highlighting the side effects of protracted, low-dose radiation exposure. A phantom 
model and thermoluminescent dosimeters to measure radiation dose to operators during 
routine coronary angiograms with the aim of examining dose to specific target regions. These 
measurements enabled the tabulation of values that could convert readily available patient 
dose metrics to operator dose. Another finding of this study was that conventional monitoring 
used at this institution using a single under apron dosimeter underestimated radiation dose up 
to 68%. Evidence-based recommendations to mitigate the risk of radiation-induced side 
effects – via the use of radiation protection tools to high exposure regions – were also 
presented. 
Conventional dose measurement methods provide a retrospective analysis of dose only, while 
current methods of real-time dose measurement, through their reliance on visual feedback, 
represent an additional cognitive load to the operator. The final project in this thesis involved 
the creation and analysis of a real-time dose detector that was capable of providing visual, 
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audible and tactile feedback to the operator. The main advantage of this detector was assessed 
to be the ability to provide ongoing feedback during the procedure that could result in real 
time procedural modifications to reduce the dose. Furthermore, the vibration module of the 
operator providing tactile feedback can be programmed to activate during high dose rates (to 
allow procedural modifications) or during dose thresholds (to serve as a reminder as regards 
high dose delivery). One such prototype detector was created and tested, with calibration 
results showing comparable results to available products and reasonable comfort for the 
operator. The aim of this device was to aid educational stimulation and awareness of 
radiation dose, with the eventual aim of clinical application. 
9.1 Further Work 
The validation of the code presented in the automated dose management system would be 
valuable if the dose calculations are to be used clinically. In this thesis, the information 
collected was only used to set benchmarks, to raise awareness and to compare exposure 
parameters following optimisation techniques. Specifically, the validation of peak skin dose 
to predict tissue reactions would be a useful project. At the time of writing, regulatory 
requirements only require exposure parameters DAP and Reference Air Kerma be recorded, 
however, if accurate skin dose calculations were available then this may also be a useful 
metric to be recorded to account for patient future radiation exposures on already 
compromised skin locations. Such an experiment would require the use of Gafchromic® film 
placed on a torso phantom in a simulated procedure. The directly measured skin dose can 
then compared to the calculated dose from the software. 
Further clinical testing of the manipulation of frame rates in the diagnostic quality image may 
also be worthwhile. It is noted as part of this study that although operators commented on the 
diagnostic clarity when the frame rate is lowered from 15 normal to 10 low, this was quickly 
surpassed, and 10 fps low became the norm. Although lowering the frame rate to 7.5 fps may 
be ambitious it may have its use in certain image acquisitions. Further work should be done 
to quantitatively assess image quality parameters. A quantitative description of image quality 
versus dose optimisation settings would be useful in guiding other establishments. 
In regards to operator dose, the work presented in this thesis has all been done in simulated 
environments. Both experiments can be used as a blueprint for clinical studies. The first staff 
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experiment focused on measuring the radiation dose to different regions of a mannequin. This 
could be repeated by attaching TLDs to the same anatomical regions as the mannequin to the 
operator during patient cases. This may be cumbersome, and perhaps a body suit with TLD 
pouches can be developed and worn over the scrubs or lead apron. This would serve to 
validate the results presented in this thesis and provide more clinically significant results. 
The real-time radiation detector could be used to understand the behavioural changes of 
operators when constant radiation safety feedback is provided. For instance, what kind of 
sensory feedback is best in achieving radiation reduction outcomes? Alternatively, does 
providing consistent feedback result in a significant behavioural change that results directly 
in radiation dose reduction. There have been studies looking at the latter however they were 
in conjunction with patient monitoring software and not standalone. 
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Appendix A 
Ethics approval for Ultra-Low pulse fluoroscopy in coronary angiography study obtained for 
Chapter 5 of this thesis.  
 
 
Austin Health New Study Ethics Approval Letter Version 1, dated 03 Sept 2015 based on 
REx Ethics Approval letter template Version 1, dated 6 Aug 2015     Page 1 of 2 CW 
 
 
AUSTIN HEALTH HUMAN RESEARCH ETHICS COMMITTEE 
 
 ETHICAL APPROVAL FOR NEW STUDY 
 
 
Dr Robert Chan  
Austin Health 
Cardiology Department 
145 Studley Road 
Heidleberg VIC 
3084 
Australia 
 
 
17 February 2016 
 
Dear Dr Robert Chan 
 
AU RED HREC Reference Number: LNR/16/Austin/24 
 
Austin Health Project Number: Audit 16/24 
 
Project Title: Ultra-low pulse rate fluroscopy during routine diagnostic coronary angiography 
 
 
 
I am pleased to advise that the above project amendment has received ethical approval from the Austin 
Health Human Research Ethics Committee (HREC).  This HREC is organised and operates in accordance 
with the National Health and Medical Research Council’s (NHRMC) National Statement on Ethical Conduct in 
Research Involving Humans (2007), and all subsequent updates, and in accordance with the Note for 
Guidance on Good Clinical Practice (CPMP/ICH/135/95), the Health Privacy Principles described in the 
Health Records Act 2001 (Vic) and Section 95A of the Privacy Act 1988 (and subsequent Guidelines). 
 
HREC Approval Date: 17/02/2016 
 
Participating Sites: 
 
Ethical approval for this project applies at the following sites: 
 
Site 
Austin Health 
Warringal Private Hospital 
 
Approved Documents: 
 
The following documents have been reviewed and approved:  
 
Document Version Date 
Audit Activity Application incorporating protocol  1.0 29 January 2016 
 
Site Specific Assessment: 
 
SSA Authorisation is required at all sites participating in the study. SSA must be authorised at a site before 
the research project can commence.  
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Appendix B 
Ethics approval for Radiation dose optimization in interventional cardiology study obtained 
for Chapter 6 of this thesis.  
  
 
 
 
 
Austin Health Ethics Approval of New Project Version 5, dated 29 Jul 2016  Page 1 of 2 
 
 
 
 
 
 
AUSTIN HEALTH HUMAN RESEARCH ETHICS COMMITTEE 
 
 ETHICAL APPROVAL  
 
 
Ms Tegan Clark 
Austin Health 
 
31 August 2016 
 
Dear Ms Tegan Clark, 
 
HREC Reference Number [AU RED HREC reference number]: LNR/16/Austin/373 
 
Austin Health SITE REFERENCE Number: Audit 16/373 
 
Project Title: Radiation Dose Optimisation in Interventional Cardiology 
 
 
I am pleased to advise that the above project has received ethical approval from the 
Austin Health Human Research Ethics Committee (HREC).  The HREC confirms that your 
proposal meets the requirements of the National Statement on Ethical Conduct in Human 
Research (2007). This HREC is organised and operates in accordance with the National 
Health and Medical Research Council’s (NHRMC) National Statement on Ethical Conduct in 
Human Research (2007), and all subsequent updates, and in accordance with the Note for 
Guidance on Good Clinical Practice (CPMP/ICH/135/95), the Health Privacy Principles 
described in the Health Records Act 2001 (Vic) and Section 95A of the Privacy Act 1988 (and 
subsequent Guidelines). 
 
HREC Approval Date: 31 August 2016 
 
Ethical approval for this project applies at the following sites: 
 
Site 
Austin Health 
 
Approved Documents: 
 
The following documents have been reviewed and approved: 
 
Document Version Date 
Audit Activity Application Form incorporating the Protocol 1.0 29 August 2016 
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Appendix C 
Raw data for calibration of Real-Time detector developed in chapter 8 of the thesis. 
 
Page 1 of 2 Form ARS-FORM-CL1
Linearity Test Spreadsheet Calibration Rail:
SGS ARS Job No.:
Calibration Date:
Monitor Display Units:
Completed By:
Table 1.
664.5 mm - Indicated Dist 145 GBq source Range: Auto
1535.0 mm - Actual Dist
Filter 24 Bgd None Filter 3 Filter 6 Filter 12
No  100% 68.5% 50.5% 23.1%
1 2 4997 3938 3158 1669
2 0 4929 3879 3122 1682
3 1 5071 3924 3191 1678
4 0 5079 3986 3122 1692
5 1 5008 3870 3221 1619
Mean 0.80 5016.80 3919.40 3162.80 1668.00
Std. Dev. 0.75 54.74 42.13 38.82 25.59
Mean - Bgd 5016.00 3918.60 3162.00 1667.20
4022.12 2755.55 2029.56 928.71
Average Linearity Std. Dev. 120.66 82.67 60.89 27.86
1.51 Linearity 1.25 1.42 1.56 1.80
Resolution 1 1 1 1 1
Table 2.
2644.5 mm - Indicated Dist 145 GBq source Range: Auto
3515 mm - Actual Dist
Filter 24 Bgd None Filter 3 Filter 6 Filter 12
No  100% 68.5% 50.5% 23.1%
1 0 1331 964 763 358
2 1 1431 969 811 379
3 0 1416 986 776 360
4 0 1461 1006 774 357
5 0 1456 1017 808 385
Mean 0.20 1419.00 988.40 786.40 367.80
Std. Dev. 0.40 46.97 20.52 19.40 11.79
Mean - Bgd 1418.80 988.20 786.20 367.60
752.99 515.87 379.96 173.87
Average Linearity Std. Dev. 22.59 15.48 11.40 5.22
2.00 Linearity 1.88 1.92 2.07 2.11
Resolution 1 1 1 1 1
Table 3.
1264.5 mm - Indicated Dist 145 GBq source Range: Auto
2135 mm - Actual Dist
Filter 24 Bgd None Filter 3 Filter 6 Filter 12
Yes  100% 68.5% 50.5% 23.1%
1 0 289 179 119 57
2 1 243 176 129 72
3 1 241 159 127 62
4 1 260 195 134 64
5 0 241 190 128 57
Mean 0.60 254.80 179.80 127.40 62.40
Std. Dev. 0.49 18.53 12.51 4.84 5.54
Mean - Bgd 254.20 179.20 126.80 61.80
118.47 81.16 59.78 27.35
Average Linearity Std. Dev. 3.55 2.43 1.79 0.82
2.18 Linearity 2.15 2.21 2.12 2.26
Resolution 1 1 1 1 1
Air Kerma Rate (uGy/h)
Filter
Filter
Filter
Actual Air Kerma Rate (uGy/h)
Actual Air Kerma Rate (uGy/h)
Actual Air Kerma Rate (uGy/h)
2
15-12474
01-Dec-15
Counts per second (CPS)
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Page 1 of 2 Form ARS-FORM-CL1
Linearity Test Spreadsheet Calibration Rail:
SGS ARS Job No.:
Calibration Date:
Monitor Display Units:
Completed By:
Table 1.
664.5 mm - Indicated Dist 145 GBq source Range: Auto
1535.0 mm - Actual Dist
Filter 24 Bgd None Filter 3 Filter 6 Filter 12
No  100% 68.5% 50.5% 23.1%
1 2 4997 3938 3158 1669
2 0 4929 3879 3122 1682
3 1 5071 3924 3191 1678
4 0 5079 3986 3122 1692
5 1 5008 3870 3221 1619
Mean 0.80 5016.80 3919.40 3162.80 1668.00
Std. Dev. 0.75 54.74 42.13 38.82 25.59
Mean - Bgd 5016.00 3918.60 3162.00 1667.20
4826.54 3306.66 2435.47 1114.45
Average Linearity Std. Dev. 144.80 99.20 73.06 33.43
1.25 Linearity 1.04 1.19 1.30 1.50
Resolution 1 1 1 1 1
Table 2.
2644.5 mm - Indicated Dist 145 GBq source Range: Auto
3515 mm - Actual Dist
Filter 24 Bgd None Filter 3 Filter 6 Filter 12
No  100% 68.5% 50.5% 23.1%
1 0 1331 964 763 358
2 1 1431 969 811 379
3 0 1416 986 776 360
4 0 1461 1006 774 357
5 0 1456 1017 808 385
Mean 0.20 1419.00 988.40 786.40 367.80
Std. Dev. 0.40 46.97 20.52 19.40 11.79
Mean - Bgd 1418.80 988.20 786.20 367.60
903.59 619.05 455.95 208.64
Average Linearity Std. Dev. 27.11 18.57 13.68 6.26
1.66 Linearity 1.57 1.60 1.72 1.76
Resolution 1 1 1 1 1
Table 3.
1264.5 mm - Indicated Dist 145 GBq source Range: Auto
2135 mm - Actual Dist
Filter 24 Bgd None Filter 3 Filter 6 Filter 12
Yes  100% 68.5% 50.5% 23.1%
1 0 289 179 119 57
2 1 243 176 129 72
3 1 241 159 127 62
4 1 260 195 134 64
5 0 241 190 128 57
Mean 0.60 254.80 179.80 127.40 62.40
Std. Dev. 0.49 18.53 12.51 4.84 5.54
Mean - Bgd 254.20 179.20 126.80 61.80
142.16 97.39 71.73 32.82
Average Linearity Std. Dev. 4.26 2.92 2.15 0.98
1.82 Linearity 1.79 1.84 1.77 1.88
Resolution 1 1 1 1 1
Ambient Dose Equivalent Rate H*(10) 
(uSv/h)
Filter
Filter
Filter
Actual Ambient Dose Equivalent Rate H*(10) (uSv/h)
Actual Ambient Dose Equivalent Rate H*(10) (uSv/h)
Actual Ambient Dose Equivalent Rate H*(10) (uSv/h)
2
15-12474
01-Dec-15
Counts per second (CPS)
